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In vitro Functional Analysis of Sry Related Transcription Factor Sox11 in Adult 
Neurogenesis 
 
SUMMARY 
The generation of new neurons from neural stem cells is restricted to two regions in 
the adult mammalian brain: the subventricular zone of the lateral ventricle and the 
subgranular zone of the hippocampal dentate gyrus. In both regions, adult 
neurogenesis encompasses different steps including activation of quiescent stem cells, 
proliferation of stem and progenitor cells, neuronal fate commitment and maturation 
and integration of newly developed neurons. Extrinsic and intrinsic pathways regulate 
all these stages of adult neurogenesis. Sets of transcription factors from different 
families act together to control cell fate decisions of progenitor cells and 
differentiation of precursors into each lineage.  
In this study Sry related high-mobility-group box (Sox) transcription factor 11 is 
focused on to understand its role in adult neurogenesis. Initially, Sox11 expression in 
adult neurogenic lineages was investigated. Sox11 expression was detected in 
neurogenic lineages of adult mice brain in combination of identified cellular markers. 
It was shown that Sox11 expressing cells do not express Sox2 or GFAP that are 
neural stem cell markers and Sox11 expressing cells also express immature neuronal 
markers like doublecortin (DCX) and beta III tubulin (Tuj1). As a conclusion it was 
shown in this study that Sox11 is expressed in immature neuronal precursors of adult 
rostral migratory stream and dentate gyrus. To answer the question whether Sox11 
play a role in immature neuronal precursors of adult neurogenic lineages, Sox11 in 
vitro gain of function analysis was performed. Sox11 was overexpressed in the 
cultured adult hippocampal stem/progenitor cells (AHPs) derived from adult rats by 
electroporation and viral transduction of overexpression cassette. These adult rat 
hippocampal progenitors were kept under two separate differentiation conditions for 
four days. Both AHPs were then analyzed with the expression of immature neuronal 
marker doublecortin. It was shown that doublecortin (DCX) expression was induced 
in Sox11 overexpressing cells. This observation indicates that Sox11 overexpression 
promotes neuronal differentiation of adult hippocampal progenitors in vitro. 
Additionally in this study Sox11 effect on DCX promoter was investigated in human 
embryonic kidney (HEK) cells via luciferase assay. Even very little amount of Sox11 
(8ng/30x106 cells) highly induced (50 folds) DCX expression. This result gives the 
idea that Sox11 is an upstream element of DCX promoter. Finally, short hairpin 
RNAs (shRNAs) against Sox11 was produced to generate a tool for loss of function 
analysis to clarify its role in adult neurogenesis. Four different target sequences were 
selected inside the mouse Sox11 coding sequence. Four different shRNA were 
synthesized depending on the selected sequences.    Afterwards functionality of 
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Sox11-shRNAs was tested for further approaches via Western blot and psi-CHECKTM 
luciferase assay system. It was shown that two of the produced shRNAs were 
functional and they could be used for loss of function analyses.Sry !li#kili 
Transkripsyon Faktörü Sox11’in Eri#kin Nörojenezdeki Rolünün Hücre Kültüründe 
Ara#tırılması  
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Sry !li"kili Transkripsyon Faktörü Sox11’in Eri"kin Nörojenezdeki Rolünün 
Hücre Kültüründe Ara"tırılması 
 
ÖZET 
Yeti#kin memeli beyninde yeni sinir hücreleri sadece subventriküler alanın ventrikül 
yatay duvarında ve hipokampusün subgranüler kısmında olu#turulmaktadır. Bu iki 
kısımda da gerçekle#en nörojenez; sessiz kök hücrelerinin aktifle#tirilmesi, kök hücre 
ve projenitör hücrelerin proliferasyonu, nöronal kaderin seçilmesi ve yeni geli#mi# 
sinir hücrelerinin entegrasyonu adımlarından olu#maktadır. Yeti#kinlerdeki 
nörojenezin tüm bu adımları içsel ve dı#sal yol izleriyle kontrol edilmektedir. Farklı  
ailelerden transkripsyon faktörleri projenitör hücrelerin kader seçiminde ve farklı 
hücre soylarına diferansiye olmalarında birlikte etkili olmaktadır.   
Bu çalı#mada Sry ili#kili transkripsyon faktörü Sox11’in yeti#kin nörojenezdeki 
rolünün anla#ılması amaçlanmı#tır. Öncelikle Sox11 proteininin yeti#kin nörojenik 
alanlardaki ekspresyonu ara#tırıldı. Bunun için farklı hücresel markırlar kullanılarak 
yeti#kin fare beyninde nörojenik alanlardaki Sox11 protein ekspresyonu tespit edildi. 
Bu çalı#mada Sox11 sentezleyen hücrelerin nöral kök hücre markırları olan Sox2 ve 
GFAP’yi sentezlemedi"i fakat olgunla#mamı# nöron markırlarından doublekortin 
(DCX) ve beta III tübülini (Tuj1) sentezledi"i belirlenmi#tir. Sox11’in rostral göç 
yolunda ve hipokampuste sadece olgunla#mamı# nöronal precursor hücrelerde 
ekspresyonu gözlendi. Buradan yola çıkarak Sox11’in yeti#kin nörojenik alanlardaki 
olgunla#mamı# nöronal sinir hücrelerinde nasıl bir fonksyonu oldu"unu anlamak için 
Sox11 gen ifadesi hücre kültüründeki yeti#kin hipokampus hücrelerinde iki ayrı 
sistem ile fazlaca arttırıldı. Sox11 ekspresyon kaseti yeti#kin sıçan hipokampüs hücre 
kültürüne elektroporasyon ve viral transdüksyon yolu ile gönderildi. Bu yeti#kin sıçan 
hipokampüs projenitör hücreleri dört gün süresince iki farklı nöronal diferansiyasyon 
kondisonunda tutuldu. Her iki diferansiyasyon #artlarındaki  Sox11’i fazlaca eksprese 
eden yeti#kin hücrelerde, olgunla#mamı# nöronal markır doublekortinin ekspresyonu 
incelendi ve bu hücrelerde doublekortin ekspresyonunun arttı"ı gözlendi. Bu çalı#ma, 
Sox11 gen ifadesinin arttırılmasıyla yeti#kin hipokampüs hücrelerinin nöronal 
farklıla#masının arttı"ını göstermi#tir. Bu çalı#mada ayrıca Sox11’in DCX promotor 
bölgesine olan etkisi insan embryonik böbrek hücre kültüründe lusiferaz ölçümü ile 
incelendi. Çok az miktardaki Sox11 (8ng/30x106 hücre)’in bile DCX promotor 
aktivitesini yüksek oranda (50 kat) arttırdı"ı gözlendi. Son olarak, Sox11’in 
yeti#kinlerde nörojenik alanlardaki rolünü aydınlatmak için Sox11’in gen ifadesini 
susturacak Sox11’e spesifik RNA interferanz molekülleri sentezletildi. Sox11’in 
anlamlı dizisi içerisinden dört farklı hedef sekansı seçildi ve onlara ba"lı olarak RNA 
 xiii 
interferanz molekülleri sentezletildi. Western blot ve psi-CHECKTM lusiferaz 
sistemleriyle hazırlanmı# RNA interferanz dizilerinin Sox11’e ne kadar spesifik ve 
fonksyonel oldukları ara#tırıldı. Bunlardan iki tanesinin hücrede fonksyonel olarak 
Sox11’i susturdu"u gösterildi.   
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1. INTRODUCTION 
1.1 Adult neurogenesis 
Stem cells that have the potential to develop into different specialized tissue cells are 
one of the most promising areas of science in terms of their clinical potential. 
Embryonic stem cells from the inner cell mass of the blastula are multipotent cells 
that give rise to all body tissues except placenta. Stem cells in some of the adult 
tissues like blood, bone and epithelia, have the ability to renew themselves and to 
replace the tissue cells with the new ones under certain physiological conditions 
(Morrison and Spradling, 2008). Since stem cells have high potential repair capacity, 
cell based therapies using these stem cells to treat diseases are in great importance. 
Although in the traditional view of the brain after birth is considered post-mitotic, it 
was a great wonder if there are stem cells in adult central nervous system. Neural 
stem cells (NCS) and restricted progenitors are both found in many regions of the 
central nervous system (CNS) throughout life whereas it was a central dogma that 
‘no new neuron is added to adult brain’ till 1965. Embryonic neural stem cells 
(NSCs) that give rise to neuroepithelial cells arise from ectoderm. The 
neuroepithelial cells then produce radial glia that generates fetal and adult NSCs in 
the CNS. Stem cells in the CNS are ‘self-renewing’ to produce indistinguishable 
progeny from themselves, ‘proliferative’ to undergo continuously mitotic division 
and ‘multipotent’ to generate neurons and glia lineages i.e. astrocytes, 
oligodendrocytes (Weiner, 2007). Neurogenesis, producing functionally integrated 
neurons from progenitors was believed to occur only in the embryo (Ramon y Cajal, 
1913) In 1967, first evidence that neurogenesis occurs in mature rat and guinea pig 
brain was shown (Altman and Das). Neurogenesis in adult monkeys (Gould et al., 
1999) and then in the human hippocampus (Eriksson et al., 1998) was demonstrated 
with the generated technique of labeling the dividing neurons during S phase with a 
synthetic thymidine analogue bromodeoxyuridine (BrdU) and detecting the labeled 
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cells by immunohistochemistry. Nowadays it is generally accepted that neurogenesis 
occurs in distinct parts of the adult brain (Gross CG, 2000).  
Neurogenesis actively occurs throughout the life of most mammals in subventricular 
zone (SVZ) of the lateral ventricles and in the subgranular zone (SGZ) of the dentate 
gyrus of the hippocampus (Lie et al., 2004) (Fig 1.1).  
 
Figure 1.1: Discrete regions that neurogenesis is active in the adult mammalian brain 
(Elizabeth Gould, 2007). 
NSCs in the SVZ of the lateral ventricles generate transiently amplifying cells. They 
differentiate into immature neurons that migrate over a great distance with each other 
in chains through the rostral migratory stream (RMS) to the olfactory bulb. The 
migrating neurons are covered by astrocytes. After the immature neurons reach to the 
olfactory bulb, new neurons migrate radially to the outer layers of the olfactory bulb. 
Immature neurons differentiate into granule neurons and periglomerular neurons 
(Ming and Song, 2005).  
NSCs in the SGZ of the hippocampus that have radial processes projected through 
the granular cell layer (GCL) and tangential processes extended to the GCL and the 
hilus give rise to transiently amplifying progenitors. Those cells then differentiate 
into immature neurons that migrate into the GCL where they become dentate granule 
cells. Migrated immature neurons extend their axonal projections along the mossy 
fiber pathway to the Ammon’s horn or cornu ammonis (CA3) of the hippocampus 
pyramidal cell layer and their dendrites toward the molecular layer. Newly developed 
granule neurons then integrate into the neuronal network (Ming and Song, 2005). 
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1.2 Markers of neurogenesis 
Developmental stages of adult neurogenesis are identified with expression of unique 
sets of markers and morphology differences between cells. This fundamental 
information is very important for learning origins of new neurons and further clinical 
applications. 
Olfactory bulb (OB) neurogenesis initiators are located in the lateral walls of the 
lateral ventricles in the SVZ. These cells are slowly proliferating neuronal precursor 
type B cells with astrocytic properties like glial fibrillary acidic protein (GFAP) 
positive intermediate filaments, light cytoplasm, gap junctions, and glycogen 
granules. These cells give rise to transiently amplifying type C cells in the SVZ 
(Doetsch et al., 1997). Type C cells then form type A migrating neuroblasts. Type A 
cells migrate from the lateral walls through the RMS to the OB in chains that are 
covered by type B cells (Alvarez-Buylla et al., 2002). Type A cells can be identified 
by doublecortin (DCX) and polysialylated form of the neural cell adhesion molecule 
(PSA-NCAM) expression that are both associated with neuronal migration. Neuron 
specific class III beta tubulin (Tuj1) is also expressed in those immature neurons 
(Kempermann, 2006). During the migration along the RMS, type A cells continue to 
divide and initiate neuronal maturation and a few of type A cells become calretinin 
positive (Jankovski and Sotelo, 1996). When they reach to the OB, they differentiate 
into mature neurons that express NeuN and calretinin.  
 
Figure 1.2: Model of adult neurogenesis in SVZ (Kempermann, Adult Neurogenesis 
pg: 148). 
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In the adult SGZ similar to SVZ, primary progenitor type 1 cells have triangular-
shaped soma, radial glia like morphology with long apical processes and astrocytic 
properties like GFAP expression (Seri et al., 2001). Type 1 cells give rise to 
transiently amplifying progenitor type 2 cells. Type 2 cells express nestin similar to 
type 1 cells but do not express GFAP. They have short processes located more or less 
parallel to the SGZ. They are classified under two groups such as DCX negative type 
2a and DCX positive type 2b (Kronenberg et al., 2003). Type 2b cells have both 
properties of precursor cells expressing nestin and lineage determined immature 
neurons expressing DCX and PSA-NCAM. Afterwards type 2 cells generate type 3 
migrating neuroblasts that are located horizontally or more vertically to the SGZ. 
Type 3 cells that express DCX but do not express nestin radially migrate into the 
granular cell layer. Type 3 post-mitotic cells that are characterized by calretinin 
expression start to differentiate into granule cells (Kempermann et al., 2003). When 
they become mature granule cells, calretinin is converted to calbindin expression 
(Brandt et al., 2003).    
 
Figure 1.3: Model of adult hippocampus neurogenesis (Kempermann et al., 2004). 
1.3 Regulation of neurogenesis with transcription factors 
To better understand the active neurogenesis taking place only in the restricted brain 
regions, it is important to elucidate the regulation of neurogenesis sequential phases. 
Adult neurogenesis is highly controlled by intracellular and intercellular factors at all 
steps, including proliferation, fate specification, migration, survival and synaptic 
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integration (Zhao et al., 2008). It was identified that the genetic background effects 
hippocampal neurogenesis, survival and differentiation as well as total hippocampus 
volume in adult mice (Kempermann and Gage, 2002). Furthermore activation or 
repression of gene expression is controlled by transcription factors that identify gene 
profiles of different cell types (Hevner et al., 2006). Moreover neurogenesis in the 
adult has similarities with the developing brain. For example, transcription factors do 
not only control particular steps in the differentiation of precursors into the different 
cell types but also regulate several aspects of neuronal identity in both adult and 
developing brain (Hevner et al., 2006). Sets of transcription factors from different 
families act together to control cell fate decisions and differentiation into each 
lineage (Lefebvre et al., 2007). However, it is really less known about transcriptional 
regulation of adult neurogenesis (Hodge et al., 2008). Sry related high-mobility-
group box (Sox) transcription factor 11 is focused on in this study to understand its 
role in adult neurogenesis.  
1.3.1 Sry-related high-mobility-group  (HMG) box (Sox) transcription factors 
There are 20 identified members of Sry-related high-mobility-group  (HMG) box 
(Sox) group proteins that are expressed in the vertebrates (Wegner, 2005). Sex-
determining region on the Y chromosome Sry was the first identified Sox group 
family protein (Gubbay et al., 1990). At the same time it was demonstrated that Sry 
belongs to a wide family afterwards called Sry related group box (Sox) genes (Denny 
et al., 1992). Sox proteins regulate the transcription with its high-mobility-group 
(HMG) box domain. HMG box domains are associated in DNA binding, DNA 
bending, protein-protein interactions and nuclear import or export. When non-histone 
chromosomal proteins were separated by SDS-PAGE, three unrelated DNA binding 
proteins were identified forming a high mobility group protein.  Sox group proteins 
are one of the groups containing HMG box domain that distinguishes in the 
superfamily by sharing 46% or more identity to Sry in the HMG box (Dy et al., 
2008). Sox group proteins bind to DNA with a specific sequence from the minor 
groove with the twisted L shape HMG domain included three alpha helices and an 
amino terminal beta strand and bend it to an angle from 30°C to 110°C (Fig 1.4). By 
the modification of DNA confirmation, transcription of specific genes is facilitated 
(Lefebvre et al., 2007). 
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All Sox proteins bind DNA through a consensus (A/T)(A/T)CAA(A/T)G  sequence 
but, the specificity of binding is regulated by other cell-type specific binding partners 
that are not clearly identified for all Sox proteins. Class III Pit-Oct-Unc (POU) 
transcription factors Octs and Brns have been identified as regulator binding partners 
of Sox proteins (Kim et al., 2008).  
 
 
Figure 1.4: Structural properties of Sox HMG box domain.  L shaped HMG box 
domain with 3 alpha helices (blue) binds to minor groove of linear DNA and bend it 
to an angle from 30°C to 110°C (Lefebvre et al., 2007). 
There are 8 different groups in Sox family proteins and members of the same groups 
share a high degree of identity (70 to 95%) within and outside of the HMG box 
(Table 1.1).  
Table 1.1: Classification of mammalian Sox group proteins. Sox 12 and 22 are the 
same in mouse and in human. Sox 15 and 20 are also the same. (Wegner, 2005)  
  Group A 
 
  Sry 
 Group B1 
 
            B2 
 
  Sox1 
  Sox2 
  Sox3 
  Sox 14 
  Sox 21 
  Sox 21 
  Group C 
 
  Sox 4 
  Sox 11 
  Sox 12 (Sox22) 
   Group D 
 
  Sox 5 
  Sox 6 
  Sox 13 
   Group E 
 
  Sox 8 
  Sox 9 
  Sox 10 
   Group F 
 
  Sox 7 
  Sox 17 
  Sox 18 
   Group G 
 
  Sox 15 (Sox 20) 
   Group H 
 
  Sox 30 
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Sox proteins have important roles in preserving stem cell characteristics, maintaining 
a pluripotent state under certain conditions and cell fate determination into specific 
lineages as well (Wegner, 2005). For instance, specifically Sox2 acts cell 
autonomously to maintain the pluripotency of stem cells that later generate all 
embryonic and trophoblast cell types (Avilion et al., 2003). Sox proteins are 
expressed in specific tissues during development and differentiation; therefore, 
mutations in these genes cause multiple developmental malformations i.e. Sox 3 
mutations result in mental retardation (Laumonnier et al., 2002), Sox 9 mutations are 
the reason of campomelic dysplesia with sex reversal (Foster et al, 1994), Sox10 
mutations cause the neurocristopathy syndromes Waardenburg-Hirschsprung and 
Yemenite deaf-blind hypopigmentation (Inoue et al., 2003). The Sox B1 genes Sox1, 
Sox2 and Sox3 are expressed in all neurons and have redundant roles in supplying 
the wide developmental potential and the identity of stem cells both in the embryo 
and in the adult (Wegner and Stolt, 2005).  When the proneural proteins activate the 
expression of Sox B2 genes that repress the activity of Sox B1 proteins, development 
of neurons is initiated in the embryo.  Additionally proneural genes activate Sox C 
genes (Sox11 and Sox4) that establish neuronal properties redundantly (Lfebvre et 
al., 2007).  
1.3.2 Sox11  
Sox11 is a group C protein that shares a high degree identity with Sox4 and Sox22 in 
both HMG box domain and C terminal region (Lfebvre et al., 2007).  However 
Sox11 and Sox4 have similarities in structure and function; Sox11 activates genes 
more strongly than Sox4 because of more stable alpha helical structure in its 
transactivation domain (Dy et al., 2008). Sox11 has a C terminal transactivation 
domain that acts as an activator synergistically with the POU proteins Brn-1 and Brn-
2 (Weigle et al., 2005). HMG box domain is located in the N terminal third of Sox11 
and an internal acidic domain of Sox11 acts as inhibitor of its DNA binding affinity 
in Electron Mobility Shift Assays (EMSA) (Wiebe et al., 2003). Sox11 is widely 
expressed in embryonic branchial arches, lung, gastrointestinal tract, pancreas, 
spleen, kidneys, gonads, mesenchyme and additionally human and mouse fetus in the 
central and peripheral nervous system (Dy et al., 2008). Sox11 deficient mice died at 
birth from heart defects and they have developmental abnormalities in arterial 
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outflow, lung and skeletal formation. Additionally Sox11 deficiency causes asplenia, 
open eyelids, cleft lip and palate (Sock et al., 2004). Sox11 ubiquitous expression in 
CNS and peripheral nervous system supposedly shows that it involves in 
development and regeneration of the brain. It has been shown that Sox11 promotes 
neurite growth and neuron survival. In chicken embryo, it was demonstrated that 
Sox11 is important for neuronal differentiation (Bergsland et al., 2007). It was 
proposed that it is essential for expression of pan-neuronal genes like beta III tubulin. 
Highly activation of beta III tubulin reporter constructs by Sox11 in COS cells was 
concluded as beta III tubulin is the only identified downstream element of Sox11 
(Bergsland et al., 2007). However Sox11 is an important protein for embryonic 
neuronal differentiation, nothing is known about its function in the adult 
neurogenesis.    
1.4 Aim of the study 
The transcriptional cascade that regulates neuronal differentiation in adult brain is 
largely unknown. Sry related HMG box transcription factor Sox11 has been 
demonstrated to actively regulate embryonic neuronal differentiation. The aim of the 
study was to analyze Sox11 function in adult neurogenesis. For this purpose, Sox11 
expression in adult neurogenic lineages was investigated. Sox11 expressing cells 
were identified by colocalization of immature neuronal markers such as doublecortin 
and beta III tubulin. 
In this study Sox11 role in adult neurogenesis was investigated with in vitro Sox11 
gain of function analysis. Sox11 was overexpresed in cultured adult hippocampal 
stem/progenitor cells (AHPs) derived from adult rats by electroporation and viral 
transduction. Additionally effect of Sox11 as a transcription factor on promoters of 
immature neuronal markers doublecortin and beta III tubulin (Tuj1) was analyzed. 
With this experiment if Sox11 is an upstream element of immature neuronal markers 
(i.e. doublecortin and Tuj1) was analyzed. Finally, short hairpin RNAs (shRNAs) 
against Sox11 were produced to generate a tool for loss of function analysis. 
Functionality of Sox11-shRNAs was tested for further approaches. Sox11 
knockdown study might give more ideas about its function in adult neurogenesis.  
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2. MATERIALS 
2.1 Chemicals 
Table 2.1: List of chemicals. 
Chemicals  Company 
 
Country 
Acrylamid Sigma-Aldrich USA 
Agarose Biozym Germany 
Ampicillin    Sigma-Aldrich USA 
Ampuwa water             Fresenius Germany 
APS Sigma-Aldrich USA 
BSA Sigma-Aldrich USA 
Chloroform Roth Germany 
ECL Western blotting  
Detection reagents 
Amersham UK 
-Gluc se Sigma-Aldrich USA 
Dapi Sigma-Aldrich USA 
Developer A AGFA Belgium 
Developer B AGFA Belgium 
DMEM HAM´s F12 PromoCell Germany 
DMEM(1X) with sodium pyruvate                                                                  GIBCO/Invitrogen USA 
DMEM/F-12 with GlutaMax                                                                            GIBCO/Invitrogen USA 
DMSO Sigma-Aldrich USA 
DNA ladder (100bp) NEB Germany 
DNA ladder (1kb)                                              NEB Germany 
DTT Fermentas Germany 
ECL Hyperfilm Amersham UK 
EDTA Sigma-Aldrich USA 
EGTA Roth Germany 
Ethidiumbromid (1 mg/mL)                                                                                     Roth Germany 
Ethanol (100%)                                                                                     Merck Germany 
Fetal Bovine Serum (FBS)  
(Ultra low Endotoxin)                                                                     
PAA Germany 
FGF2                                 Peprotech USA 
FSK         Sigma-Aldrich USA 
Glycerol Sigma-Aldrich USA 
Glycin Roth Germany 
HCl (32%)                                                                                               Merck Germany 
Hepes Roth Germany 
Isopropanol (100%)                                                                                 Merck Germany 
KCl Merck Germany 
Natural mouse laminin                                                                            Invitrogen USA 
L-Glutamine (200mM)                                                                            GIBCO/Invitrogen USA 
Loading dye (6x) MBI Fermentas Germany 
2-Mercaptoethanol Sigma-Aldrich USA 
Methanol (100%)                                                                                     Merck Germany 
N2-supplement (100X)   Invitrogen Germany 
Normal donkey serum Chemicon Germany 
PAGE-Prestained Protein Ruler Fermentas Germany 
Paraformaldehyde Roth Germany 
Passive Lysis Buffer Promega USA 
Polymount Polysciences USA 
PSF (penicillin, streptomycin, fungizone)                                                                                         GIBCO/Invitrogen USA 
PVDF membrane Pall Corporation USA 
Rapid fixer AGFA Belgium 
Skim milk powder Fluka Switzerland 
SYBR! GreenI Invitrogen USA 
TEMED Sigma-Aldrich USA 
Triton X-100 Roth Germany 
Trizol Invitrogen USA 
Trizma-Base Sigma-Aldrich USA 
Trypsin-EDTA GIBCO/Invitrogen USA 
Tween 20 Roth Germany 
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2.2 Enzymes and enzyme buffers 
The enzymes and enzyme buffers used in this study are listed. 
Table 2.2: List of enzyme and enzyme buffers.  
  Enzymes Company Country 
  CIP NEB Germany 
  HpaI NEB Germany 
  HindIII Fermentas Germany 
  NotI NEB Germany 
  RQ1 DNase Promega USA 
  SalI Fermentas Germany 
  SmaI Fermentas Germany 
  T4-Ligase  NEB Germany 
  XbaI NEB Germany 
  Xho I NEB Germany 
  Enzyme buffers   
  Buffer R Fermentas Germany 
  Buffer Tango Fermentas Germany 
  Ligase Buffer  NEB UK 
  NEB 1/2/3 NEB UK 
  PCR mix (2.5x) Eppendorf Germany 
  RQ1 Buffer Promega USA 
  RQ1 Stop buffer Promega USA 
2.3 Kits  
The kits used in this study are listed. 
Table 2.3: List of kits. 
Kits Company Country 
Dual-Luciferase Reporter 1000 Assay System 
 
Promega USA 
NucleoSpin Plasmid Kit                                                                Macherey Nagel Germany 
QIAquick Gel Extraction Kit Qiagen  Germany 
Rat NSC Nucleofector  Amaxa Biosystems Germany 
Pure Yield Plasmid Midiprepsystem                                 Promega USA 
SuperScript III Invitrogen USA 
SV Total RNA Isolation  System Promega USA 
 
2.4 Plasmids 
The plasmids used in this study are listed. 
Table 2.4: List of plasmids. 
Plasmids Company/Suppliers Country 
pLentiLox 3.7 Van Parijs Laboratory USA 
psiCHECK2 Promega Germany 
psiCHECK3 Dr. Ralf Kühn, Helmholz Zentrum, 
Munich 
Germany 
pGL3-Basic Promega Germany 
pKSPS Modified pBluescript in Fred Gage 
Laboratory 
USA 
pCAT-490F Dennis et al., 2006 USA 
pCAT-131F 
 
Dennis et al., 2006 USA 
pCAT-131R Dennis et al., 2006 USA 
phuDCX3509-FFluci Karl et al., 2005 Germany 
CAG-IRES-GFP  Gage Laboratory USA 
CAG-Sox11-IRES-GFP Hisato Kondoh Laboratory Japan 
CAG-Sox11-Flag-IRES-GFP Hisato Kondoh Laboratory Japan 
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2.5 Antibodies 
The antidodies used in this study are listed. 
Table 2.5: List of antibodies. 
Antibody Company  Country Catalog # Dilution used 
Primary antibodies     
chicken anti-GFP Aves Labs, Inc. USA GFP-1020 1:1000 
gennie pig anti-GFAP Adv. Immuno. USA 031223 1:1000 
goat anti-doublecortin Santa Cruz 
Biotechnology 
USA sc-8066 1:1000 
goat anti-GFP Molecular Probes Germany A-6455 1:1000  
goat anti-SOX11 Santa Cruz 
Biotechnology 
USA sc-17347 1:500 
mouse anti-ß actin Abcam UK ab6276 1:1000 
mouse anti-ß-III-tubulin Sigma-Aldrich USA T5076 1:3000 
mouse anti-calbindin Swant Switzerland 300 1:2000 
mouse anti-flag Sigma USA F1804 1:1000 
rabbit anti-GFAP DAKO cytomation Denmark Z0334 1:1000 
rabbit anti-doublecortin Abcam UK ab18723 1:1000 
rabbit anti-calbindin Swant Switzerland CB-38a 1:1000 
rabbit anti-Sox2 Chemicon USA AB5603 1:1000 
rabbit anti-Sox11 Chemicon USA AB5776 1:1000 
rabbit anti-calretinin Swant Switzerland 769914 1:1000 
Secondary antibody     
Alexa488 conjugated donkey 
 
 anti rabbit 
Invitrogen USA A11055 1:1000 
goat anti-mouse HRP 
conjugated 
Jackson 
ImmunoResearch 
Laboratories Inc 
UK 115-035-003 1:10000 
goat anti-rabbit HRP conjugated Cell signaling USA 7074 1:10000 
Cy 5 conjugated donkey anti-
goat  
Jackson 
ImmunoResearch 
Laboratories Inc 
UK 705-175-747 1:250 
Cy 3 conjugated donkey anti-
mouse  
Jackson 
ImmunoResearch 
Laboratories Inc 
UK 715-165-151 1:250 
Cy 3 conjugated donkey anti-
rabbit  
Jackson 
ImmunoResearch 
Laboratories Inc 
UK 711-165-152 1:250 
FITC conjugated donkey anti-
chicken  
Jackson 
ImmunoResearch 
Laboratories Inc 
UK 703-095-155 1:250 
Cy 3 conjugated donkey anti-
goat  
Jackson 
ImmunoResearch 
Laboratories Inc 
UK 705-165-147 1:250 
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2.6 Other equipments 
The laboratory eqiupments used in this study is listed. 
Table 2.6: List of other equipments. 
Equipments Company Country 
5100 Cryo 1°C Freezing container                                                                 NalgeneLabware USA 
Accu-jet pro Pipetaid                                                                                                     Brand USA 
BioPhotometer    Eppendorf Germany 
Blaubrand counting chamber                                                                          Brand USA 
Centrifuge 5415 D                                                                                           Eppendorf Germany 
Centrifuge 5417 R        Eppendorf Germany 
Cellstar pipettes                                                                           Greiner bio-one Germany 
Confocal microscope Fluoview 1000 Olympus USA 
Cover slips                                                                                   Menzel-Glaser Germany 
Cryoblock      Medite Medizintechnik GmbH Germany 
Cryotube vials                                                                              Nunc Denmark 
Curix 60 (photo developer) AGFA Belgium 
Disposal cuvette UVette                                                              Eppendorf Germany 
Elka microscope slides                                                                Assistent Germany 
Fluorescence microscope DMI 6000B                                                            Leica Germany 
Gelsystem Mini                                                                                                Peqlab Germany 
Glass Cover Slips                                                                           Menzel-Glaser Germany 
HeraCell 150 incubator                                                                                    Kendro UK 
HeraCell Tissue Culture hood Kendro UK 
Light microscope  Zeiss USA 
Mastercycler ep gradient Eppendorf Germany 
Motor pestle Sigma Aldrich USA 
Power supply                                                                                                    BioRad USA 
Reaction tube 15 ml                                                                    Falcon USA 
Reaction tube 50 ml                                                                    Falcon USA 
Rotamax 150                                                                                                    Heidolph Germany 
Rotilabo 96 well Micro testplates and lids                                   Roth Germany 
Safe lock tube 1.5 ml Eppendorf Germany 
Safe lock tube 2 ml                                                                     Eppendorf Germany 
SM2000R sliding microtome                                                                           Leica Germany 
Sorvall Evolution High Speed Centrifuge                                                       Thermo Science USA 
SuperFrost microscope slides                                                      Menzel-Glaser Germany 
Surgical disposal scapels                                                             Braun USA 
 Thermomixer comfort                                                                                      Eppendorf Germany 
Tissue Culture dishes10 cm                                                         Falcon USA 
Tissue Culture ware 24 well plate                                                Falcon USA 
Tissue Culture ware 12 well plate  Falcon USA 
Vac-man Laboratory vacuum manifold Promega Germany 
UV spectrometer Eppendorf Germany 
2.7 Organisms and cell lines 
The used organisms and cell lines are listed. 
Table 2.7: List of organisms and cell lines. 
Organisms and cell lines Company/Suppliers 
E. coli Top10 F- mcrAD(mrr-hsdRMS-mcrBC)  F80lacZDM15 DlacX74 
recA1 araD139 D(ara-leu)7697 galU galK rpsL (StrR) endA1 
nupG 
Company: Invitrogen 
Human embryonic kidney (HEK) 293T cells HEK 293 (human embryonic kidney) was first established in 
1977 as a permanent adherent cell line of human embryonic 
kidney after transformation with human adenovirus type 5 
(Graham et al., 1977). 
 
Rat adult hippocampal progenitor (AHP) cells Fred Gage Laboratory 
Mouse strain C57/Bl6 male All mice were raised in the local ani al husbandry of the 
Helmholtz Zentrum Munich. They were handled according to 
the European guidelines for laboratory animals.  
The used wild type strain was C57/Bl6. This strain was 
originally bred by C.C. Little 1921. Strain 6 was separated 
1937. 
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2.8 Buffers and solutions  
The buffers and solutions used in this study are listed together with their recepies.  
Agar plates 
32 g/l LB (Luria-Bertani) Agar 
0.1 mg/ml Ampicillin 
Agarose gel (2%) 
6g Agarose 
300 ml TAE buffer (1x) 
Agarose gel (1%) 
3g Agarose 
300 ml TAE buffer (1x) 
Blocking solution for immunostaining of tissue 
3% donkey serum 
2.5% TritonX-100 
in TBS 
Blocking solution for immonocytochemistry  
1% donkey serum 
0.1% TritonX-100 
in TBS 
Borate Buffer (0.1 M) 
3.0915 g Boric acid 
500 ml H2O 
pH 8.5  
Cryoprotectant 
250 ml Glycin 
250 ml Ethylene Glycol 
500 ml 0.1 M Phosphate buffer 
HBS (2x) 
8 g NaCl 
0.37 g KCl 
201 mg Na2HPO4
.
7H2O 
1 g Glucose 
5 g Hepes 
add H2O up to 500 ml pH 7.04 
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Loading dye for Agarose-Gels (6x) 
0.2 ml 10mM Tris/HCl pH 7.5 
10 ml Glycerol (100%) 
4 ml EDTA (0.5 M) 
0.05 g Xylencyanol 
0.05 g Bromphenol blue 
20 ml H2O 
Paraformaldehyde (4%) 
40 g                              Paraformaldehyde  
500 ml H2O 
Add NaOH and heat until solution is clear  
500 ml 0.2 M Phosphate buffer 
pH 7.4   
PBS (10x) 
80 g NaCl 
2 g KCl 
14.4 g Na2HPO4 
2.4 g KH2PO4 
800 ml H2O 
pH 7.2   
Phosphate-Buffer (0.2 M) 
16.56 g Sodium phosphate (Na3PO4) monobasic 
65.70 g Sodium phosphate (Na3PO4) dibasic 
add H2O up to 3 L  
SDS (Sodium dodecyl sulfate) (10x)   
100g SDS 
900 ml H2O 
Heat it up to 68°C 
pH 7.2  
add H2O up to 1 L  
SDS-Probe buffer (Laemmli-Buffer) (5x) 
7.815 ml Tris/ HCl (2 M, pH 6.8) 
25 ml Glycerin 
5 g SDS 
12.5 ml Mercapto ethanol 
25 mg Bromophenol blue 
add H2O up to 50 ml   
Sucrose (30%) 
150 g                           
 
Sucrose 
500 ml                         
 
Phosphate buffer (0.1 M) 
Store at 4°C 
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TAE (50x) 
242 g Tris Base 
57.1 ml Acetic acid 
100 ml EDTA (0.5 M, pH 8.0) 
add H2O up to 1 L  
Tris buffered Saline (TBS) (10x) 
80 g NaCl 
2 g KCl 
250 ml Tris/HCl pH 7.5 (1 M) 
add H2O up to 1 L   
TBST (10x) 
1 L TBS (10x) 
10 ml Tween 20 
Western blot running buffer (10x) 
30.285 g Tris Base 
144.13 g Glycin 
10 g SDS 
add H2O up to 1 L 
Western blot transfer buffer (10x) 
81.6 g Bicine 
104.6 g Tris Base 
40 ml EDTA (0.5 M, pH 8.0) 
177.5 mg Chlorbutanol (1,1,1-Trichlor-2-methyl-2-
propanol) 
add H2O up to 2 L  
Western blot transfer buffer (1x) 
25 ml Transfer Buffer (10x) 
25 ml Methanol 
200 ml H2O 
Western blot stripping buffer  
3.125 ml Tris / HCl (1 M, pH 6.8) 
10 ml SDS (10%) 
add H2O up to 50 ml 
346.6 !l Mercaptoethanol 
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SDS-Polyacrylamid gel  
The components of SDS-Polyacrilamid are listed. 
Table 2.8: Components of SDS-Polyacrylamid gel.   
Seperating gel 10% 
1.8 ml H2O 
1.9 ml Lower Tris (1M pH 8.8) 
1.25 ml 40% Acrylamid 
50 !l 10% SDS 
5 !l TEMED 
25 !l 10% APS 
Stacking gel  
2.27 ml H2O 
0.375 !l Upper Tris (1M pH 6.8) 
0.3 ml 40% Acrylamid 
20 !l 10% SDS 
3 !l TEMED 
30 !l 10% APS 
2.9 Software 
The used software is listed.  
Table 2.9: Used software list.   
Software 
Company Country 
FV10-ASW 1.6 Viewer Olympus USA 
LAS AF Lite Leica software       Leica Germany 
 Photoshop! CS3 Adobe! USA 
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3. METHODS 
3.1 DNA 
3.1.1 Plasmid DNA isolation 
Plasmid DNAs can be extracted from the bacteria by selective alkaline denaturing of 
chromosomal DNA as described by Birnboim and Doly (1979). After neutralization, 
alkaline denatured high molecular weight chromosomal DNA renatures selectively, 
and forms an insoluble aggregate leaving plasmid DNA in the supernatant. Plasmid 
DNA purification Kit (Nucleospin, Macherey-Nagel) was used for isolation of 
plasmids, and up to 25 !g DNA was isolated. Transfection requires pure DNA 
samples; thus Pure Yield Plasmid Midiprep system (Promega, #A2495, USA) was 
used for DNA samples that were used for transfection. All the procedures were 
carried according to the manufactures protocols.  
3.1.2 Determination of DNA and RNA concentration 
Both DNA and RNA absorb UV light very efficiently that serves concentration 
measurement possibility by an UV spectrometer.    
DNA and RNA concentrations were determined by a photometer (BioPhotometer, 
Eppendorf). Absorption of the DNA sample at A260 nm was measured and DNA 
concentration was calculated with the following formulas. 
1 A260 =50 ng/ml dsDNA 
1 A260=40 ng/ml RNA 
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3.1.3 DNA precipitation 
To remove ethanol residues from DNA samples and to make dilutions for 
appropriate DNA concentrations additional DNA purification procedure was 
performed. 3 M NaAc was added in 1/10 volume of total DNA volume. Addition of 
100% ethanol in 2.5x of the total DNA volume was followed by incubation on ice for 
30 minutes. DNA was precipitated by centrifugation (4°C; 30 minutes; 13000 rpm) 
and additional wash was performed in 70% ethanol by centrifugation (4°C; 10 
minutes; 13000 rpm). DNA was dried and then resolved in nuclease free water.  
3.1.4 DNA fragments separation with agarose gel electrophoresis 
Agarose gel electrophoresis allows separation of DNA fragments by their charge and 
mass differences. DNA is negatively charged because of its phosphate backbone and 
it migrates toward the anode when it is placed in an electric field. Furthermore, 
frictional force of the agarose acts as a molecular sieve for fragments that are going 
to be separated according to their sizes. Depending on the concentration of agarose, 
0.02-50 kb long DNA fragments can be separated. Agarose gel concentration 
between 0.6-2% is suitable for separation of linear DNA fragments of 0.1-25 kb 
(Sambrook et al., 1989).   
DNA samples that were mixed with 6x loading buffer were loaded on a 1-2% gel that 
was prepared in 1xTAE buffer with 0.2 !g/ml ethidium bromide. To detect small 
amount of DNA samples on the gel, 2xTAE buffer was prepared with SYBR green 
(1:10000). DNA fragments were separated using an electrophoresis chamber (Bio-
Rad) for "1 hour at 80 mV and visualized under UV light.  
3.1.5 Subcloning of DNA fragments 
To be able to use a luciferase reporter plasmid, 490F, 131F and 131R Tuj1 partial 
promoter sequences were cut out of the pCAT basic vector (Dennis et al., 2002) and 
cloned into pGL3 basic vector (Figure 3.1). 
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Figure 3.1: pGL3 vector map (Promega, USA). 
pGL3 vector itself does not have any suitable restriction enzyme site to provide 
ligation of digested fragments in 5’ to 3’ direction; thus,  after digestion from pCAT 
vector, pKSPS shuttle vector was used (modified pBluescript, Fred Gage laboratory, 
vector map is given in Appendix A). pKSPS was digested by using HindIII and SalI 
restriction enzymes according to the following procedure and incubated at 37°C 
overnight (Table 3.1). 
Table 3.1: Restriction digestion reaction of pKSPS. 
5 !g DNA 
0.5 !l HindIII 
0.5 !l SalI 
3 !l Buffer  
add H2O up to 30 !l 
The digested shuttle vector pKSPS was treated with Calf Intestine Alkaline 
Phosphatase (CIP) for 1 hour at 37°C to remove 5’ phosphate groups from the vector 
to avoid its self-ligation. 
Double digested pKSPS and pCAT490F, pCAT131F, pCAT131R vectors were 
loaded on a 1% agarose gel and digested DNA fragments were extracted from the gel 
with the QIAquick gel extraction kit (Qiagen, #28704, Germany) according to the 
manufactures protocol. Before proceeding ligation reaction, concentrations of DNA 
fragment 490F, 131F, 131R and pKSPS were determined roughly on an agarose gel. 
490F, 131F and 131R fragments were ligated into the pKSPS vector according to the 
following procedure and incubated at 16°C overnight (Table 3.2). T4 DNA ligase 
catalyses the covalent joining of DNA fragments with the requirement of ATP. 
Enzyme form a phosphodiester bound between 3’ hydroxyl and 5’ phosphate end of 
dsDNA fragments. 
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Table 3.2:  Ligation reaction of pKSPS vector with Tuj1 partial promoter sequences. 
5 !l Insert (490F/131F/131R) 
2 !l pKSPS 
1 !l  T4 DNA Ligase 
1 !l T4 Buffer 
add H2O up to 10 !l    
 
Ligation mixture was transformed into chemocompetent Top10 Escherichia coli 
bacterial cells. The ligation reaction (10 !l) was added into 100 !l of competent 
cells. Cells were incubated on ice for 30 minutes and subsequently heat shocked at 
42°C for 1 minute. Cells were placed on ice for 2 minutes. Following addition of 1 
ml LB media into the cells, cells were incubated at 37°C for 1 hour in a thermal 
shaker (900 rpm). 50 !l of transformed bacteria were plated on agar plates containing 
75 !g/!l ampicillin and incubated at 37°C overnight. Six different single bacterial 
colonies were picked and grown overnight in 5 ml LB medium containing 75 !g/!l 
ampicillin.  
Plasmid DNAs from the putative clones were purified with NucleoSpin Plamid Kit 
(Macherey-Nagel, #740-588.50, Germany) and digestion confirmation was 
performed to test the presence of inserts.  Digested DNAs were analyzed on an 
agarose gel. Positive clones were selected and 490F, 131F and 131R fragments were 
cut out of the vector by double digestion of SmaI and XhoI enzymes in order to 
ligate fragments into the SmaI/XhoI digested and CIP treated pGL3 vector to 
perform luciferase assays.  
3.2 RT PCR 
3.2.1 Total RNA isolation from tissue  
RNA was isolated from adult mouse hippocampal tissue and olfactory bulb using 
Trizol reagent from Invitrogen. Hippocampal tissue and tissue from olfactory bulb 
were dissociated from 9 weeks old adult male C57/BL mouse immediately after they 
were sacrificed. 1 ml of Trizol was added to 50-100 mg of tissue in a 1.5 ml reaction 
tube and incubated for 5 minutes at RT. Tissue was homogenized by using a 2 ml 
syringe.  0.2 ml chloroform was added per 1 ml Trizol reagent and the solution was 
vortexed for 15 seconds. After incubation at room temperature for 3 minutes, the 
mixture was centrifuged at 4°C 12000 rcf for 15 minutes. The aqueous phase was 
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then transferred to a new tube and precipitated with 0.5 ml isopropanol. After 10 
minutes room temperature incubation time, centrifugation was performed at 4°C 
12000 rcf for 30 minutes. The obtained RNA pellet was washed with 75% ethanol 
and centrifuged again (4°C; 12000 rcf; 5 minutes). The pellet was briefly dried at 
room temperature and dissolved in 10 !l RNAse free water. RNA concentration was 
measured by a photometer (BioPhotometer, Eppendorf) as described before (3.1.2 
Determination of DNA and RNA concentration). Isolated RNA was stored at -80°C. 
3.2.2 DNase treatment of isolated RNA 
In order to remove any DNA from the isolated RNA, DNase treatment was 
performed with the chemicals from SV Total RNA Isolation System kit (Promega, 
#Z3101, USA) in the following procedure (Table 3.3). 
Table 3.3: DNase treatment reaction of isolated RNA. 
5 !g RNA 
1 !l RQ DNase  
1 !l RQ DNase Buffer 
add RNase free H2O up to 10 !l 
Reaction mixture was incubated at 37°C for 30 minutes. Afterwards the reaction was 
stopped by adding 1!l of RQ Stop solution and incubating at 65°C for 10 minutes. 
3.2.3 Complementary DNA (cDNA) synthesis 
DNase treated RNA was reverse transcribed into cDNA using SuperScript III first 
strand cDNA kit (Invitrogen, #18080-400, USA). 5 !g of RNA was used as template 
for reverse transcription (Table 3.4).  
Table 3.4: First strand cDNA synthesis reaction.  
5 !g RNA 
1 !l Oligo dT primer 
1 !l Annealing Buffer 
add H2O up to 8 !l 
The reaction was incubated for 5 minutes at 65°C and then immediately placed on 
ice for at least 1 minute. After a brief centrifugation, 10 !l 2x First-Strand reaction 
mix and 2 !l Superscript Enzyme mix were added on ice. After a brief centrifugation 
of the samples, cDNA synthesis was performed with the following program (Table 
3.5) on a thermal cycler (Mastercycler ep gradient, Eppendorf). cDNA probes were 
stored at -20°C.  
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Table 3.5: First strand cDNA synthesis program. 
25°C 10 minutes 
50°C 50 minutes 
85°C 5 minutes 
4°C " 
3.2.4 PCR 
Nucleic acid sequences are enzymatically amplified via repeated cycles of 
denaturation, oligonucleotide annealing, and DNA polymerase extension by 
polymerase chain reaction (PCR) (Gibbs et al., 1990). PCR amplification was 
performed with the cDNA from mouse hippocampus and olfactory bulb using a 
thermal cycler (Mastercycler ep gradient, Eppendorf). 
Primers ordered from Sigma-Genosys to amplify the mouse Sox11 cDNA were used 
(Table 3.6). The expected size of amplified DNA is 489 bp.  
Table 3.6: Primer sequences used for Sox11 amplification. 
Primer Direction Sequence (5´#  3´) 
Mouse Sox11 Forward TCA GCT GCT GAG GCG CTA CAG 
3.   Reverse GAA CAC CAG GTC GGA GAA GTT CG 
 
PCR amplification reactions were prepared in a 25 !l reaction mixture:  
Table 3.7: PCR amplification reaction.   
1 !l cDNA 
0.1 !g Forward primer 
0.1 !g Reverse primer 
10 !l 2,5xPCR mix (contains Taq Polymerase, dNTP)  
add H2O up to 25 !l 
The following PCR program was used (Table 3.8).  
Table 3.8: The PCR program was used to amplify Sox11.  
Step Temperature Duration # of Cycles 
Denaturation 94°C 3 minutes 1 
94°C 15 sec 
68°C 45 sec 
Amplification 
72°C 1 minute 
 
40 
Final Extention 72°C 2 minutes 1 
 4°C $  
 
PCR products were afterwards analyzed on a 2% agarose gel. 
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3.3 RNA Interference 
RNAi that was first discovered in plants (Akashi et al., 2001), Caenorhabditis 
elegans (Kamath et al., 2001) and Drosophila (Kennerdell et al., 2000) is a post-
transcriptional gene silencing mechanism to protect organisms against viruses and 
foreign RNA molecules. When dsRNAs are introduced into a cell, ribonuclease III 
(RNase III) type protein Dicer processed them to "22 nt short interfering RNA 
(siRNA) duplex with 2-nt overhangs at each 3’ end (Bernstein et al., 2001).  
Generated siRNAs are associated with the RNA-induced silencing complex (RISC) 
that specifically targets and cleaves homologous RNA sequences (Bernstein et al., 
2001). After introducing chemically synthesized siRNAs mimicking Dicer cleaved 
substrates to an organism, they specifically silence gene of interest (Elbashir et al., 
2001). To avoid transient effect of siRNA knockdown, DNA based expressed 
siRNAs called short hairpin RNAs (shRNA) are generated (Kim, 2003). shRNAs are 
cloned into plasmid after a RNA polymerase III promoter such as  U6. When they 
are transcribed by RNA polymerase III in the nucleus, Dicer cleaves them to 
generate siRNAs (Kim, 2003).   
To knock down Sox11, 4 different shRNA constructs were designed with a length of 
19 bases. They were designed with siRNA Target Designer program from Promega 
(www.promega.com/siRNADesigner/default.htm) and one of the siRNA target 
sequences was the same used by Bergsland et al. (2007). For primer designing, T 
was added to the beginning of the target sequence, G(N18), to  reproduce U6 
promotor in -1. A loop sequence (TTCAAGAGA) was added behind the G(N18) that 
was then followed by reverse complement of G(N18). 6 Ts were added as a 
terminator sequence (Figure 3.2). The antisense primer was designed with additional 
5´ end AGCT nucleotides to produce XhoI overhang. Primers were synthesized by 
Sigma-Genosys (Table 3.9). 
 
5’  T(  sense    ) TTCAAGAGA (antisense) TTTTTTC  3’ 
3’  A(antisense)AAGTTCTCT (   sense    )AAAAAAGAGCT  5’ 
Figure 3.2: Representative figure of Sox11-shRNA primers.  
 
loop sequence   XhoI  overhang 
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Table 3.9: Sox11-shRNA primer sequences. 
Primers Direction Sequence (5´# 3´) 
Sox11-shRNA 1 Forward TGGCGTCGGGCCACATCAAATTCAAGAGATTTGAT
GTGGCCCGACGCCTTTTTTC 
 Reverse TCGAGAAAAAAGGCGTCGGGCCACATCAAATCTCT
TGAATTTGATGTGGCCCGACGCCA 
Sox11-shRNA 2 Forward TGCCTTCATGGTGTGGTCCATTCAAGAGATGGACC
ACACCATGAAGGCTTTTTTC 
 Reverse TCGAGAAAAAAGCCTTCATGGTGTGGTCCATCTCT
TGAATGGACCACACCATGAAGGCA 
Sox11-shRNA 3 Forward TGAGAAGATCCCGTTCATCATTCAAGAGATGATGA
ACGGGATCTTCTCTTTTTTC 
 Reverse TCGAGAAAAAAGAGAAGATCCCGTTCATCATCTCT
TGAATGATGAACGGGATCTTCTCA 
Sox11-shRNA 4 Forward TGGCGGCCGGCTCTACTACATTCAAGAGATGTAGT
AGAGCCGGCCGCCTTTTTTC 
 Reverse TCGAGAAAAAAGGCGGCCGGCTCTACTACATCTCT
TGAATGTAGTAGAGCCGGCCGCCA 
Two complementary Sox11 primers were annealed in the annealing buffer (100 nM 
Tris-HCl pH 7.5, 1 M NaCl, 10 mM EDTA, DEPC-treated H2O) at 65°C for 10 
minutes (Table 3.10). 
Table 3.10: Oligoligation reaction of Sox11-shRNA primers. 
Primer forward (100 pM) 10 !l 
Primer reverse (100 pM) 10 !l 
Annealing buffer 5 !l 
add H2O to 50 !l 
Then, the reaction mixture was slowly cooled down to room temperature for 2 hours. 
Annealed shRNA primers that have one blunt end and one XhoI overhang were 
cloned into HpaI/XhoI digested pLentiLox 3.7 vector (Figure 3.3). In this study 
lentiviral system was used to deliver shRNAs both into dividing and nondividing 
cells. Additionally lentivirally delivered transgenes are not silenced in developmental 
phases that can be used to produce transgenic animals. It was shown that pLentiLox 
3.7 lentiviral vector delivered shRNAs silenced gene expression very stable and 
specific in different cell populations (Rubinson et al., 2003).  
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Figure 3.3: pLentiLox 3.7 vector map (Van Parijs Laboratory, USA) 
3.4 Cell Culture 
In this study an adult (8-10 weeks old) rat hippocampal progenitors (AHPs) cell line 
was used. The isolation, characterization and culturing of AHPs used in this study 
have been described previously (Palmer et al., 1997; Ray and Gage, 2006). 
Additionally, HEK 293T cells, which are human renal epithelial cell line, were used 
to be expressed cellular proteins. 293T express SV40 large T antigen that supplies 
episomal replication of SV40 origin and early promoter region included plasmids.  
All cells were cultured in a cell incubator (HeraCell 150 incubator, Kendro) at 37°C 
with 5% CO2. 
3.4.1 Culturing of rat AHPs 
Rat AHPs were cultured in DMEM/F-12 (GIBCO 31331, +GlutaMax) media 
supplemented with 1%PSF and 1%N2 supplement. FGF2 (20 ng/µl) was added to the 
media. Cells were grown on polyornithine laminin coated tissue culture plates 
(Falcon, 10 cm). Media containing FGF2 was changed every 2
nd 
day. When the 
plates were confluent with cells, cells were passaged by trypsinization. 1 ml trypsin 
was added and removed from the plate quickly. After incubation at 37°C for 2 
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minutes, cells were washed from the plate with 5 ml media and then pelleted in a 15 
ml Falcon tube via centrifugation 2 minutes at 0.3 rcf. The pellet was resuspended in 
1 ml media. 100 µl or 200 µl of diluted cellular pellet was used for 1:10 or 1:5 10 cm 
plate preparation. To split the cells on 24 well plates, cells were counted and plated at 
a density of 5x10
4 
cells per well.   
3.4.2 Freezing and thawing cells 
Cells that were pelleted as described before were resuspended in conditioned 
medium containing 10% DMSO to freeze them. Frozen cells were stored at -80°C. 
For thawing the cells, they were incubated at 37°C for a few minutes. 10 ml of media 
was added dropwise to the cells in order to slowly dilute the DMSO. Subsequently 
cells were pelleted at 0.3 rcf for 2 minutes. The pellet was resuspended in fresh 
media and cells were plated on tissue culture plates and cultured as described above.  
3.4.3 Electroporation of rat AHPs 
Rat AHPs were electroporated with the Rat NSC Nucleofector kit (Amaxa 
Biosystems) for Sox11 or as GFP protein overexpression. Expression vectors both 
have strong and ubiquitous CAG promoter that is a combination of the human 
cytomegalovirus immediate-early enhancer and a modified chicken beta-actin 
promoter (Figure 3.4). Sox11 is expressed as a GFP fusion by this vector.  
 
 
 
 
Figure 3.4: Schema of expression vectors. (A) Sox11 and (B) GFP.  
A confluent 10 cm plate was taken and cells were pelleted as described before. Four 
different electroporations can be done with one confluent plate. The pellet was 
resuspended in 100 µl/electroporation rat Nucleofector solution. This mixture was 
added to the DNA of interest and transferred to an Amaxa certified cuvette. After 
electroporation was performed with the rat high efficiency A-033 program, the 
cuvette was rinsed with 500 µl culture medium. This solution was transferred into a 
15 ml Falcon tube, followed by an addition of 2.5 ml culture medium addition. The 
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electroporated cells were mixed gently with media and 500 µl/well of mixture was 
transferred onto coated glass coverslips in a 24 well plates. The cells were then kept 
overnight under proliferating conditions and then the medium was exchanged and the 
cells were kept 3 more days under differentiation conditions. 
3.4.4 Viral transduction of rat AHPs 
Rat AHPs were transduced with Sox11 and or GFP retroviruses. Here the same 
constructs that were electroporated into rat AHPs were used to prepare retroviruses. 
For retroviral production, 20 cm 80-90% confluent 293T cell plates were split down 
to 10-12 cm plates. Cells were transfected using Lipofectamine 2000 Reagent 
(Invitrogen). For each 10 cm plate, 9 µg of Sox11/GFP overexpression construct, 6 
µg of CMVgp (promoter sequence of retrovirus) and 3 µg of vsvg (viral packaging 
sequence) were diluted in 1.5 ml Opti-MEM I (Invitrogen) and then combined with 
60 µl Lipofectamine 2000 Reagent that was diluted in 1.5 ml Opti-MEM Reduced-
Serum Medium. After 30 minutes incubation at room temperature, 3 ml of DNA-
Lipofectamine 2000 complex was added to each 10 cm plate. Plates were incubated 
overnight at 37°C. Transfection media was changed with D-MEM including fetal 
calf serum (FCS) and PenStrep. Plates were incubated for 48 hours at 37°C before 
collecting the virus. Because produced viruses were in the cellular media, virus 
containing media was centrifuged in the ultracentrifuge (4°C; 50000 rcf; 90 minutes). 
After the whole supernatant was aspirated off, the viral pellet was resuspended in 
TNE (50 mM TrisHCl pH 7.8, 130 Mm NaCl, 1 mM EDTA). Different 
concentrations of prepared viruses were transfected into 293T cells to measure the 
titer. The titer of the prepared Sox11-CAG-IRES-GFP or CAG-IRES-GFP viruses 
were both "1.8x10
5 
virus particle/ml. Sox11-CAG-IRES-GFP virus or the control 
virus were added 1 µl/well to the cultured rat AHPs in 24 well plate with coated glass 
cover slips which were plated with a density of 5x10
4
 cells/well. The cells were then 
kept overnight under proliferating conditions and then for 3 more days under 
differentiation conditions (Explained in 3.4.5 Differentiation assay). 
3.4.5 Differentiation assay 
A neuronal differentiation assay of rat AHPs was performed. Rat AHPs were plated 
after electroporation (Explained in 3.4.3 Electroporation of rat AHPs) onto coated 
glass cover slips in 24 well plates. Cells were grown overnight in their respective 
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growth medium with FGF2 to keep them under proliferating conditions. On the next 
day the 1
st
 group of cells was cultured in normal media without FGF2 to promote 
differentiation. Furthermore to enhance differentiation, forskolin (Fsk) (5µM) and 
fetal bovine serum albumin (FBS) (0.5%) were added to the 2
nd
 group of cell media 
as described before (Palmer et al., 1997). Cells were kept under these 
(differentiating) conditions for 3 more days (Figure 3.5).  
 
 
 
 1st         
condition 
 
 +FGF2 
 
 with no treatment 
 
 2nd       
condition 
 
 +FGF2 
 
 with Fsk(5µM) and FBS (0.5%) 
 
Figure 3.5: Culturing conditions for neuronal differentiation of AHPs. 
Afterwards, the cells were fixed with 4% PFA (pH 7.4) for 10 minutes and 
subsequently washed three times with TBS. Cells were stored in TBS until processed 
for immunocytochemistry. 
3.4.6 Coating of plates 
To grow rat AHPs as an adherent monolayer, Laminin and poly-Ornithin coated 
tissue culture plates were required. 5 ml Poly-ornithin (P-Orn) solution (10 !g/ml) 
was added to 10 cm plates (Falcon) to coat them. After incubation overnight under 
the tissue culture hood, plates were washed two times with sterile ampuwa water. 
Subsequently, 5 ml Laminin/PBS solution (5 !g/ml) was put on each plate for 24 h. 
Plates were wrapped in plastic on the next day and stored at -20°C until used. 
Glass cover slips were coated in 24 well plates. Glass cover slips were washed in 
acetone for 20 minutes and afterwards incubated in 100% ethanol overnight on the 
shaker before coating. Furthermore, they were incubated in 1 M HCl for one hour on 
the shaker on the next day and subsequently washed several times in sterile water. 
Washed glass cover slips were stored in 100% ethanol until used. For coating, 
washed glass cover slips were put into the wells of 24 well plates and were sterilized 
for 30 minutes by UV-light exposure under the tissue culture hood. The coating 
protocol described for the 10 cm plates was used with 50 µg/ml final P-Orn 
1
st
 day 2
nd
 day 3
rd
 day 
4
th
 day 
 
29 
concentration. 500 µl of both P-Orn and Laminin solutions were used to cover each 
well with the cover slip. 
3.4.7 Culturing of HEK 293T cells 
293T-cells were cultured in DMEM 1x (GIBCO 41966, +4.5 g/L Glucose, L-
Glutamine and Pyruvate) supplemented with 1xPSF and 10%FBS. Medium was 
changed every 2
nd
 day. When the plates were confluent, cells were passaged by 
trypsinization. To split cells on 24 well plates, cells were counted and at a density of 
3x10
4
 cells plated per well.  
3.4.8 Transient transfection of HEK 293T cells via calcium phosphate method 
Exponentially growing cells were replated in growth medium 24 hours before 
transfection and then transfected at 60-70% confluence. For transfection of 10 cm 
plates, maximum 10 µg DNA was mixed with H2O in 1095 µl total volume. 155 µl   
2 M CaCl2 was added. Then 1250 µl of 2xHBS was added dropwise while gently 
mixing. The transfection mixture was incubated at room temperature for 3 minutes 
and then added to the growth media of the cells. After 24 hour, the medium of the 
transfected cells was refreshed. Cells were harvested 48 hours after transfection. For 
transfection of 24 well plates, half of the reaction mix described before was prepared 
and of this a 100 µl was added per well. 
3.5 Luciferase Assay 
Luciferase protein catalyzes the ATP dependent oxidation of luciferin that ends up in 
detectable light emission. Luciferase assay was performed not only to analyze the 
effect of Sox11 protein on DCX and Tuj1 promoters but also to test the knock down 
efficiency of the produced shRNA constructs against Sox11.  
For Tuj1 promoter analysis, 1.5 µg pGL3 vector that has partial promoter sequences, 
3 µg of Sox11-IRES-GFP/CAG-GFP with 0.1 µg Renilla luciferase vector were 
prepared in calcium phosphate transfection mix. For DCX promoter analysis, 1.5 µg 
phuDCX3509-FFluci (vector map is given in Appendix A) and Sox11-IRES-GFP in 
different concentrations (8 ng, 16 ng, 24 ng, 32 ng, 40 ng, 80 ng, 160 ng) with 0.1 µg 
Renilla luciferase vector were prepared in calcium phosphate transfection mix. HEK 
293T cells on 24 well plates were transfected with described transfection mix and 
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were lysed 48 hours after transfection with 150 µl/well Passive Lysis Buffer (in 1:5 
dilution with H2O). Chemiluminescense was measured with 5 µl of cell lysate by the 
luminometer. The luciferase activity was calculated in Relative Light Units (RLU) 
and as a ratio of Firefly activity/Renilla activity.  
shRNAs were tested quantitatively in psiCHECK
TM
-2 vector with luciferase activity 
measurement. psiCHECK
TM
 vectors give the possibility to check the shRNAs effect 
on the expression of a target gene fused to the reporter gene. Reporter gene of the 
vectors is Renilla luciferase and the gene of interest can be cloned into downstream 
of Renilla luciferase translational stop codon. When the shRNA is produced against 
the gene of interest, fusion mRNA is degraded by the cleavage of shRNA (Figure 
3.6). Decreased Renilla luciferase activity gives the shRNA effect in quantitative 
manner.  
 
Figure 3.6: Action mechanism of psiCHECK
TM
-2 vector. 
To test the knock down efficiency of shRNAs against Sox11, full length Sox11 gene 
sequence was cloned into 3’ of the Renilla luciferase translational stop codon in 
psiCHECK
TM
-2 vector (Figure 3.7). The vector has additionally a firefly luciferase 
sequence driven by a second promoter to be used as an internal control of luciferase 
activity. 0.25 µg of psiCHECKTM-2 vector including full length Sox11 and 0.25 µg 
of shRNA constructs in pLentiLox 3.7 vector were transfected into HEK 293T cells. 
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Cell harvesting and luciferase activity measurement were done as described before. 
The luciferase activity was calculated in Relative Light Units (RLU) and as a ratio of 
Renilla activity/Firefly activity.  
 
Figure 3.7: psiCHECK
TM
-2 vector map. 
3.6 Protein Biochemistry  
3.6.1 Preparation of protein extracts from cells  
Transiently transfected HEK 293T cells were used for protein extract preparation. 
The used assay is based on different salt concentrations specialized to isolate 
transcription factors (Bumsted-O´Brien et al., 2007). Cells of confluent HEK 293T 
cell 10 cm culture plates (Falcon) were lysed with 150 !l Buffer A (10 mM Hepes 
pH 7.9, 10 mM KCl, 0.1 mM EDTA, 0.1 mM EGTA, 2 mM DTT) placed on ice for 
5 minutes and shortly vortexed after 10% 10x Igepal addition. Cellular debris was 
pelleted by centrifugation for 1 minute at 10000 rpm (4°C). The supernatant 
containing the cytoplasmic proteins was separated from the pellet, which contains the 
nuclear extract. The nuclear membrane was degraded after addition of 90 !l Buffer B 
(10 mM Hepes pH 7.9, 10 mM KCl, 0.1 mM EDTA, 0.1 mM EGTA, 2 mM DTT, 
400 mM NaCl, 1% Igepal) by mixing in overhead shaker (4°C; 15 minutes). After a 
centrifugation at 10000 rpm for 5 minutes the supernatant, which contains the 
nuclear proteins, was combined with cytoplasmic proteins.  
3.6.2 Protein concentration measurement 
Protein concentration was determined by the Bradford Protein Assay (BioRad) with 
the spectrophotometer (BioPhotometer, Eppendorf). The principle of the assay is 
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shifting of the maximum absorbance of acidic dye Coomassie Brilliant Blue G-250 
from 465 nm to 595nm when binding to a protein occurs. 
Bradford assay reagent was prepared with 1:4 dilutions in H2O. Protein standard 
curve was made with protein standards prepared in the same buffer combination as 
the samples to be assayed. According to the standard curve, protein concentration 
was measured. 
3.6.3 Electrophoresis of proteins 
Sodium dodecyl sulfate polyacrylamide gel electrophoresis (SDS-PAGE) is used to 
separate proteins according to their electrophoretic mobility. SDS is an anionic 
detergent that dissolves hydrophobic molecules and attached them a negative charge. 
When a cell is treated with SDS, the membranes will be dissolved, all the proteins 
will be solubilized, their secondary-tertiary structures will be denatured and they will 
be applied negative charge in proportion to their weight by the detergent. When the 
denatured proteins are applied to polyacrylamide gel submerged in a suitable buffer, 
an electric current is applied across the gel that causes the migration of negatively 
charged proteins across the gel towards the anode. Each protein will migrate 
differently depending on their size and they will be separated through the gel matrix.  
Proteins were resolved on SDS polyacrylamide gels using the Bio-Rad vertical mini 
gel system. Equal amounts of proteins (100 µg) were mixed with 5x Laemmli buffer 
and were denatured at 95°C for 5 minutes. Denatured proteins were loaded on a 10% 
SDS-Polyacrylamide gel. The proteins were collected on the stacking gel at 50 V and 
then they were separated on separation gel at 100 V. Running buffer recipe for SDS-
PAGE is described in Buffers and Solutions. 
3.6.4 Western blot 
Proteins were transferred from the gel to a PVDF (Polyvinylidenfluorid) membrane 
(Pall Corporation) with blotting buffer in a blotting apparatus from Invitrogen. 
Blotting was performed at 30 V for 1 hour. Afterwards the membrane was blocked 
for 1 hour in 5% skim milk powder in TBST and incubated with primary antibody 
diluted in 3% BSA added TBST over night at 4°C. The next day, the membrane was 
washed 3 times for 10 minutes in TBST and then incubated in HRP conjugated 
secondary antibody at room temperature for 1 hour. Then the membrane was again 
 
33 
washed one time in TBST and then three more times in TBS for 10 minutes of each 
washing step. The bound antibodies were detected with the ECL chemiluminescence 
detection kit (Amersham). The membrane was exposed to X-ray sensitive film (ECL 
Hyperfilm, Amersham) which was developed in the photo developer (Curix 60, 
AGFA). Transfer buffer recipe for blotting is described in Buffers and Solutions. 
3.6.5 Stripping of Western blot membranes 
The previously bound antibodies to the used membranes can be removed by 
stripping. This allows to reprobe the membrane by using a second set of antibodies.  
The membrane was incubated in stripping buffer for 30 minutes at 37°C. After one 
washing step in TBST for 10 minutes the membrane can be re-blocked in 5% skim 
milk powder in TBST for 1 hour and afterwards incubated with primary antibody in 
3% BSA added TBST. Stripping buffer recipe is described in Buffers and Solutions. 
3.7 Immunohistochemistry 
3.7.1 Immunostaining of brain slices 
C57/Bl6 mice were deeply anesthetized and perfused transcardially with 4% PFA in 
PBS (pH 7.4). Brains were removed, post-fixed in 4% PFA for 24 hours and placed 
in 30% sucrose solution. Brains were cut both coronally and sagittally into 40 µm 
thick sections on a sliding microtome (SM2000R sliding microtome, Leica) on dry 
ice. Sections were collected and stored for further investigations in cryoprotectant 
solution at –20°C. Selected free floating sections for immunostaining were rinsed in 
TBS three times for 15 minutes in a 12-well plate with nets. Sections were incubated 
in blocking solution (TBS
++
; TBS containing 3% donkey serum and 0,25% Triton-X-
100) for one hour at RT. Sections were then incubated with primary antibody in 
TBS
++
 for 72 hours on overhead shaker at 4°C. On the forth day, sections were 
washed 3 times in TBS for 15 minutes and then once with TBS
++
 for 30 minutes. 
Afterwards sections were incubated for 1 hour with fluorescent conjugated secondary 
antibodies diluted in TBS
++
. Then following one washing step in TBS, sections were 
washed once with TBS containing DAPI (1:10000). After the last washing in TBS, 
sections were mounted on slides with polymount. Then sections were investigated 
under the microscopy. 
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3.7.2 Immunostaining of cells 
Fixed rat AHP cells that were stored in TBS were blocked with TBS++ (TBS 
containing 1% donkey serum and 0.1% Triton-X-100) for 1 hour. Afterwards cells 
were treated with primary antibody in TBS++ over night at 4°C. On the second day, 
cells were washed three times with TBS and subsequently blocked with TBS++ for 
30 minutes. Cells were incubated in TBS++ containing a fluorophore coupled 
secondary antibody for 2 hours at room temperature. Following one washing step 
with TBS, cells were washed once with TBS containing DAPI (1:10000). After one 
further washing step with TBS, cells were ready for investigation under the 
microscope. If they were grown on glass cover slips, cover slips were mounted on 
slides with Polymount and afterwards investigation was performed. 
3.7.3 Microscopy 
A light microscope (Zeiss), two fluorescence microscopes (DMI 6000B Leica, 
Axiovert 200M Zeiss) and a confocal microscope (Fluoview 1000 from Olympus) 
were used.  
3.7.4 Counting procedure 
To determine GFP and DCX positive cells, whole coverslip area of every well was 
observed under 20x objective of fluorescence microscope (Fluorescence microscope 
DMI 6000B, Leica; Axiovert 200M Zeiss). The number of GFP positive cells was 
counted in order to determine the percentage of both GFP/DCX and Sox11-IRES-
GFP/DCX double positive cells.  
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4. RESULTS 
4.1 RT PCR reveals that Sox11 is expressed in neurogenic lineages 
Sox11 expression was examined in adult brain/neurogenic lineages by RT PCR. For 
RT PCR, total RNA was extracted from the hippocampus and olfactory bulb using 
the Trizole reagent. cDNA was synthesized and with the first strand cDNA, PCR was 
performed with specific primers to amplify 489 bp sequence of Sox11. As a control, 
first strand cDNA reaction of isolated RNAs was done without reverse transcriptase 
addition (-RT) to exclude amplification of Sox11 out of genomic DNA.  As a 
negative control the PCR was run with a sample containing H2O instead of cDNA (-
cDNA). Amplified products were run on a 2% agarose gel and visualized with SYBR 
green (Figure 4.1). A 489 bp product of Sox11 was detected in both regions of the 
adult brain tested, in the hippocampus and olfactory bulb. The negative control 
shows the specificity of the results.  
 
489 bp 
 
Figure 4.1: Sox11 expression in adult hippocampus and olfactory bulb. RT PCR 
from total RNA of hippocampus and olfactory bulb reveals Sox11 expression. +RT = 
Reverse transcriptase included: -RT = without reverse transcriptase: -cDNA = 
negative control. 
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4.2 Sox11 is expressed in newborn immature neurons in the adult neurogenic 
lineages 
Anja Badde identified Sox11 expression pattern for the first time in adult neurogenic 
lineages with immunohistochemical detection of Sox11 in combination of different 
neural precursor markers and also mature neuronal markers (unpublished data). She 
showed that Sox11 is expressed in immature neurons in adult neurogenic lineages. In 
this present study, immunohistochemical staining of Sox11 was repeated to confirm 
these results.  
Aim of this experiment was to identify the cell types that express Sox11 in the 
RMS/OB system or hippocampus. To reveal this, immnuhistochemical detection of 
Sox11 in combination with different cell markers was performed. Cryosections were 
immunostained with Sox11 specific antibody in combination with Sox2 or GFAP as 
stem cell markers and doublecortin or beta III tubulin (Tuj1) as early neuronal 
markers and analyzed in the RMS/OB system and the hippocampus.   
As it is shown in Figure 4.2, there are Sox11 positive cells along the rostral-
migratory stream but most of them are GFAP or Sox2 negative (A). Nevertheless 
most of the Sox11 positive cells are doublecortin and beta III tubulin (Tuj1) positive 
(Figure 4.2 B). As a result, migrating neuroblasts express Sox11 that migrate along 
the RMS towards to the olfactory bulb. 
A 
 
B 
 
Figure 4.2: Sox11 expression in the RMS. In the RMS most of the Sox11 (red) 
positive cells are not Sox2 (green) or GFAP (blue) positive (A) but are doublecortin 
(green) and Tuj1 (blue) positive (B). Scale bar: 30 µm 
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Additionally, to identify Sox11 expression in the hippocampus, brain sections were 
stained with Sox11 specific antibody in combination with the stem cell marker Sox2 
or GFAP, the early neuronal marker doublecortin, calretinin or beta III tubulin (Tuj1) 
and the mature neuronal marker calbindin. According to the Figure 4.3, there are 
Sox11 positive cells located in the dentate gyrus, which are Sox2 or GFAP negative 
(Figure 4.3 A), but all Sox11 positive cells are positive for doublecortin and most of 
them also colocolized with beta III tubulin (Tuj1) (Figure 4.3B). Additionally there is 
an overlap between calretinin and Sox11 positive cells, whereas there is no 
overlapped staining between calbindin and Sox11 (Figure 4.3C). Consequently, 
Sox11 is said to be expressed in dentate gyrus in immature neuronal precursors.         
A 
 
B 
 
C 
            
Figure 4.3: Sox11 expression in the hippocampus. A) Most of the Sox11 (red) 
positive cells do not express Sox2 (green) or GFAP (blue). B) Sox11 positive cells 
are doublecortin (green) and Tuj1 (blue) positive. C) Some Sox11 positive cells are 
calretinin (green) positive but all of them are calbindin (blue) negative. Scale bar: 50 
µm. 
A schematic drawing modified from Encinas et al. summarizes the expression 
pattern of Sox11 in the hippocampus (Figure 4.4). 
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Figure 4.4: Schematic drawing of Sox11 expression in developmental stages of the 
adult hippocampus neurogenesis (modified from Encinas et al., 2006). 
4.3 Sox11 gain of function analysis  
Since Sox11 expression in neurogenic lineages was detected, in vitro gain of function 
analyses of Sox11 were performed to understand its role in adult neurogenesis. 
According to the observed Sox11 overlapped expression with doublecortin (DCX) 
and Tuj1 in tissue sections, the question for in vitro analyses were based on the 
relation in between Sox11 and DCX/Tuj1. 
4.3.1 Activation of the DCX promoter by Sox11  
To analyze whether Sox11 is able to induce the DCX promoter, phuDCX3509-
FFluci which contains the 3509 bp putative human DCX regulatory sequence driving 
the firefly luciferase gene (Karl et al., 2005) was transiently transfected to HEK 
293T cells together with Sox11-CAG-IRES-GFP vector in a dose dependent manner 
(8 ng, 16 ng, 24 ng, 32 ng, 40 ng, 80 ng, 160 ng). Firefly luciferase activity was 
normalized against the Tk driven Renilla luciferase. Since negative control for the 
transfection was CAG-IRES-GFP coding for green fluorescence protein instead of 
Sox11 was transfected together with phuDCX3509-FFluci. This study shows that 
Sox11 induces DCX promoter. Small dose (8 ng /30x10
6
 cells) of Sox11 is already 
sufficient to 50 folds activation of DCX promoter (Figure 4.5). 
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Figure 4.5: Sox11 activates DCX promoter. Transactivation of DCX-promoter 
reporter by Sox11 in a dose dependent manner.  
4.3.2 Sox11 overexpression induces DCX expression in AHPs 
Neurons, astrocytes and oligodendrocytes can be derived from adult hippocampal 
progenitors (AHPs) that are multipotent cells (Gage, 2002). To identify Sox11 
function in vitro, Sox11 was overexpressed in AHPs and was kept under neuronal 
differentiating conditions to test for a possible influence of Sox11 on neuronal 
differentiation.  
Sox11-CAG-IRES-GFP or CAG-IRES-GFP control vectors were electroporated into 
rat AHPs. Electroporated AHPs were cultured with FGF2 containing medium 
(+FGF2) overnight for proliferation of precursors. On the second day the medium 
was changed. In the first experimental condition the cells were cultured without 
FGF2 (-FGF2), and in the second experimental condition, the cells were treated with 
forskolin (5mM) and fetal bovine serum (0.5%) for 3 more days to trigger the 
differentiation. Exposure of AHPs to forskolin and fetal bovine serum has been 
shown to promote differentiation (Ray and Gage, 2006). Four days after 
electroporation, cells were fixed with 4% paraformaldehyde and immunostained for 
GFP and DCX specific antibodies. Then quantification was performed for Sox11-
IRES-GFP and GFP positive cells that were double labeled with DCX (Figure 4.6).   
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Figure 4.6: Sox11 overexpression induces DCX expression of AHPs kept under –
FGF2 conditions. Electroporated AHPs were kept one day under proliferative 
conditions +FGF2 then three more days under neuronal differentiation conditions –
FGF2. Four days after electroporation, cells were fixed and immunostained with 
GFP, DCX and Sox11 specific antibodies (A). A quantification of GFP/DCX and 
Sox11-IRES-GFP/DCX double positive cells is shown in (B). Error bars indicate 
standard deviation of two different experiments. Scale bar: 20 µm. 
After culturing the electroporated cells under neuronal differentiating conditions 
without any additional growth factors, both the GFP and Sox11 overexpressing cells 
started to express the immature neuronal marker DCX. In Sox11 overexpressing 
AHPs "63% of Sox11 positive cells were DCX double positive whereas just "24% 
of the GFP positive cells were DCX double positive (Figure 4.7B). Therefore one 
can conclude that Sox11 overexpression induces DCX expression and promotes 
neuronal differention in AHPs.  
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To reveal the effect of Sox11 on AHPs that were kept under enhanced neuronal 
differentiating conditions including forskolin (Fsk) and fetal bovine serum (FBS) 
immunostaining and counting procedures were performed as previously described. 
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Figure 4.7: Sox11 overexpression induces DCX expression of AHPs kept under 
enhanced differentiating conditions. Electroporated AHPs were kept one day under 
proliferative conditions +FGF2 followed by three more days under neuronal 
differentiating conditions –FGF2, +Fsk and +serum. Four days after electroporation, 
cells were fixed and immunostained with GFP and DCX specific antibody (A). A 
quantification of GFP/DCX and Sox11-IRES-GFP/DCX double positive cells is 
shown in (B). Error bars indicate standard deviation of two different experiments. 
Scale bar: 20 µm. 
In Sox11 overexpressing AHPs, "86% of Sox11 positive cells were DCX double 
positive whereas just "25% of the GFP positive cells were DCX double positive. 
Compared to the –FGF2 condition, there was an even higher induction of DCX 
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expression by Sox11 under enhanced differentiating condition. Therefore the 
addition of forskolin and serum has an additive effect on DCX expression in Sox11 
overexpressing AHPs. 
4.3.3 Viral overexpression of Sox11 induces DCX expression 
To confirm the Sox11 overexpression results by a second approach, Sox11-IRES-
GFP or GFP expression retroviruses were prepared and transduced into the AHPs. 
Retrovirus packaging of expression vectors was performed in HEK 293T cells. The 
titers of the Sox11-IRES-GFP or GFP retroviruses were both "1.8x10
5
 virus 
particle/ml. AHPs were plated with a density of 5x10
4 
cells/well in 24 well format 
including glass coverslips. After transduction cells were then kept overnight under 
+FGF2 proliferating conditions and then for three more days under –FGF2 
differentiation conditions. After the cells were fixed with 4% paraformaldehyde, they 
were immunostained with GFP and DCX specific antibodies. The percentage of 
GFP/DCX and Sox11-IRES-GFP/DCX were calculated. 
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Figure 4.8: Viral overexpression of Sox11 induces DCX expression of AHPs kept 
under -FGF2 conditions. AHPs were transduced with Sox11-IRES-GFP and kept 
overnight under proliferative conditions (+FGF2), followed by 3 more days under 
neuronal differentiating conditions (–FGF2). 4 days after transfection, cells were 
fixed and immunostained for GFP and DCX (A). A quantification of GFP/DCX and 
Sox11-IRES-GFP/DCX double positive cells is shown in (B). Scale bars: 20 µm. 
Because of using retroviruses, Sox11 and GFP constructs were transduced only into 
the dividing precursors. After keeping the cells under neuronal differentiation 
condition, both GFP and Sox11 transduced cells started to express the immature 
neuronal marker DCX. In Sox11 overexpressing AHPs, approximately 90% of 
Sox11 positive cells were also DCX double positive whereas only "11% of the GFP 
positive cells were DCX double positive (Figure 4.8B). This different experimental 
approach also confirmed the previously shown results that Sox11 overexpression 
induces DCX expression and promotes neuronal differentiation.   
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4.3.4 Analysis of Sox11 effect on Tuj1 partial promoter sequences  
There are three potential Sox11 binding sites on the Tuj1 promoter sequence 
identified so far. Bergsland et al. (2006) showed that Sox11 induces mouse partial 
Tuj1 promoter (from -566 to +54) "9 fold in a LacZ reporter assay. To confirm this 
result, three rat Tuj1 partial promoter sequences (490F: from -490 to +1, 131F: from 
-131 to +1, 131R: from +1 to -131) in the pCAT vector (old version) were used 
(Dennis et al., 2006). Since CAT analysis requires radioactive labeling, a luciferase 
assay was preferred for promoter analysis. For this part, promoter sequences were 
sub-cloned into pGL3 basic vector. Since there were no suitable restriction sites to 
ligate fragments directly into the pGL3 vector in 5’-3’ orientation, the pKSPS vector 
was used to shuttle the fragments. The pCAT vectors containing the Tuj1 partial 
promoter sequences and the pKSPS empty vector were digested with HindIII/XbaI 
enzymes. Digested pKSPS vector and partial promoter fragments were extracted and 
purified and then ligation reaction was performed. Afterwards, the ligation mix was 
transformed to Top10 competent bacteria and small amounts of plasmid DNA of 
selected clones were prepared. DNA was digested with HindIII/XbaI enzymes to 
select the clones that contain the insert of interest. Inserted fragments have a length 
of 490 bp (490F) or 131 bp (both 131F and 131R) and the pKSPS shuttle vector has a 
size of 3 kb. Digested samples were analyzed on a 1% agarose gel. Only one of the 
positive clones that contain the right insert in the shuttle vector was selected for each 
fragment (Figure 4.9).  
 
Figure 4.9: Test digestions of the partial Tuj1 promoter sequences ligated into the 
shuttle vector. XhoI/HindIII digestion of the (A) 490F, 131F and (B) 131R fragments 
ligated into pKSPS. Positive clones (arrows) that show a band at the right size were 
selected for further cloning. M1kb: 1kb DNA marker (NEB). 
To subclone these fragments into the pGL3 basic vector, 490F-, 131F- and 131R-
pKSPS and empty pGL3 were digested with SmaI/XhoI enzyme. Gel extracted and 
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purified 490F, 131F and 131R inserts were then ligated into the digested pGL3 
vector. Afterwards the ligation reaction was again transformed into Top10 competent 
cells and small amounts of plasmid DNA of selected clones were prepared. Purified 
DNA was digested with SmaI/XhoI enzymes to select the clones that contain the 
insert of interest. One of the positive clones that contain the right insert was selected 
for each of the three fragments (Figure 4.10). 
 
Figure 4.10: Test digestion of the partial Tuj1 promoter sequences ligated into the 
luciferase vector pGL3. SmaI/XhoI digestion of the (A) 490F, 131F and (B) 131R 
fragments ligated into pGL3. Positive clones (arrows) that show a band at the right 
size were selected for luciferase experiment. M1kb: 1kb DNA marker (NEB). 
These positive clones of the 490F, 131F and 131R fragments in the pGL3 vector 
were used in luciferase assays to analyze the effect of Sox11 effect on the Tuj1 
promoter. 
The 490F construct has 3 potential Sox11 binding sites whereas the 131F has only 1 
Sox11 binding site (Bergsland et al., 2006). These constructs, which are driving a 
firefly luciferase gene in the pGL3 basic vector, were together with Sox11-CAG-
IRES-GFP transiently transfected into HEK 293T cells. The 131R construct that is 
the reverse oriented form of the 131F construct was used as a negative control. A 
TK-Renilla-luciferase was included to each transfection to normalize the firefly 
luciferase activity. The data were analyzed using CAG-IRES-GFP as control together 
with each pGL3 vector included promoter sequences transfected HEK 293T cells. 
Normalized firefly luciferase values were again normalized depending on the 
negative control.  As it is shown in the luciferase assay data in Figure 4.11,  Sox11 
conrtaversly to the previously published data, did not significantly interact  with the 
partial promoter sequences.  
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Figure 4.11: Sox11 effect on Tuj1 partial promoter sequences detected in a 
luciferase assay.  Luciferase assay results of HEK 293T cells transfected with Sox11 
and Tuj1 partial promoter sequences. Sox11 did not significantly induce the 490F 
fragment which includes 3 Sox11 binding sites (A).  Sox11 induced 131F sequence 2 
fold (B), 131R construct was used as an internal control of 131F (C).  
4.4 Sox11 loss of function analysis 
In order to analyze the role of Sox11 with loss of function studies, shRNAs against 
Sox11 were generated and functionally tested. 
4.4.1 shRNAs were designed to knock down Sox11 
Since interference RNA has the post-transcriptional gene silencing facility, shRNAs 
designed to knockdown Sox11. 4 different shRNAs with a length of 19 bases (N19) 
were designed to specifically knock down Sox11. shRNA primers have a loop 
sequence included in between sense and anti sense strand of the N19 sequence and a 
terminator sequence in the 5’ end. Reverse primers were designed with a 5’ sticky 
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end for XhoI. Reverse and forward primers were annealed together and cloned into 
the pLentiLox 3.7. pLentiLox 3.7 vector was digested with HpaI and XhoI and then 
ligated with the shRNA primers which contain a blunt end and an XhoI sticky end. 
After the ligation reaction the reaction mix transformed into Top10 cells and small 
amounts of DNA was prepared of the clones. If the shRNA primers are correctly 
ligated into the pLentiLox 3.7 vector the fragments shift on an agarose gel about 50 
bp compared to the empty vector after digestion with XbaI and NotI. Therefore, the 
inserted fragments that contain Sox11 shRNA were running at ~500 bp whereas the 
insert that does not contain shRNA were at ~450 bp levels of the marker. The vector 
backbone alone  has a size of 7.2 kb. Six clones were tested for each primer pair. 
Digested DNA were analyzed on 2% agarose gel. Two positive clones for each 
shRNAs were sequenced and used for further experiment (Figure 4.12).  
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Figure 4.12: Test for positive clones containing Sox11-shRNA in the pLentiLox 3.7 
vector. Test digestion of Sox11-shRNA 1, 2 and 3 (A) and Sox11-shRNA 4 (B) in 
the pLentiLox 3.7 vector with XbaI/NotI enzymes. Positive clones have an expected 
size of 500 bp (arrows), negative clones a size of 450 bp. M1kb: 1kb DNA marker 
(NEB),  M100bp: 100bp marker (NEB).  
4.4.2 Functionality analysis of Sox11-shRNAs on Western blot 
To test for the functionality of designed Sox11-shRNAs, the constructs were 
transfected into HEK 293T with a full-length construct Sox11-CAG. Confluent HEK 
293T cell plates with a diameter of 10 cm were transfected with a total of 5 µg DNA 
with the Calcium Phosphate method. A negative control was included into these 
experiments to guarantee the specificity of the designed Sox11-shRNAs. For this 
purpose HEK 293T cells were transfected either with the empty pLentiLox 3.7 vector 
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or with the GFP vector in combination with Sox11-CAG. For transfection reaction, 
equal amounts of Sox11-shRNAs and Sox11-CAG were transfected (2.5 µg). 48 
hours after transfection, cells were lysed and total protein was isolated to be analyzed 
by Western blot. Sox11 antibody and beta-actin antibody that recognizes total 
amount of protein were used. 
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Figure 4.13: Knock down of Sox1 in vitro detected by Western blot. HEK293T cells 
were transfected with Sox11-IRES-GFP-CAG and four different Sox11-shRNAs. 
Transfection of either GFP alone, Sox11-Flag-CAG in combination with either 
empty pLentiLox3.7-GFP or unrelated shRNA served as negative controls. (A) 
Sox11 detection using a specific Sox11 antibody and (C) transfection efficiency 
control with total GFP detection with GFP antibody. 
As shown in Figure 4.13 Sox11 specific products are reduced at the size of 55 kD in 
Sox11-shRNA transfected cell lysates. Again, the Sox11-shRNA2 and 3 seem to be 
the most efficient ones.  The Sox11 specific product in control conditions like after 
transfection of an unrelated shRNA or an empty pLentiLox 3.7-GFP vector is not 
reduced compared to Sox11-shRNA transfections. As a loading control a GFP 
antibody staining was performed. This verifies that expression of transfected 
constructs is equal. Therefore this experiment confirms that Sox11-shRNA 2 and 3 
are functional to knockdown Sox11 in vitro.   
To verify the results shown with Sox11 antibody, the constructs were transfected into 
HEK 293T with a full-length construct Sox11-Flag-CAG. A negative control was 
included into these experiments to guarantee the specificity of the designed Sox11-
shRNAs. For this purpose HEK 293T cells were either transfected with the empty 
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pLentiLox 3.7 vector in combination with Sox11-Flag-CAG. For transfection 
reaction, equal amounts of Sox11-shRNAs and Sox11-Flag-CAG were transfected 
(2.5 µg). 48 hours after transfection, cells were lysed and total protein was isolated to 
be analyzed by Western blot. Flag antibody that recognizes the flag-tag of Sox11-
Flag-CAG and beta-actin antibody that recognizes total amount of protein were used. 
As it is shown in Figure 4.14, Sox11-Flag protein was detected around 55 kD. The 
intensity of the Sox11-Flag bands were reduced in Sox11-shRNA transfected cell 
lysates especially in the case of Sox11-shRNA 2 and 3. This experiment shows that 
shRNA 2 and 3 are functional to knockdown Sox11-Flag in HEK 293T cells.  
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Figure 4.14: Knock-down of Sox11 in HEK cells detected by Western blot. HEK 
293T cells were transfected with Sox11-Flag-CAG and four different Sox11-
shRNAs. Transfection of Sox11-Flag-CAG in combination with empty pLentiLox 
3.7 served as negative control. (A) Sox11 detection with a Flag antibody and  (B) 
total amount of protein detection with beta actin antibody. 
4.4.3 Functional analysis of Sox11-shRNAs with the psiCHECK vector system   
To test the efficiency of the shRNAs for knockdown of Sox11 in a simple 
experimental set-up, the psiCHECK
TM
 from Promega (Germany) was chosen. This 
system relies on the measurement of a Renilla-luciferase, which is fused to the 
reporter-gen of interest.  Therefore, the target sequence of Sox11 was subcloned into 
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the psiCHECK
TM
2-expression vector. The psiCHECK
TM
2 vector and the full length 
Sox11 coding sequence were digested with XhoI and NotI. Then the digested 
fragments were loaded on an agarose gel, purified and ligated. The ligation mix was 
transformed into Top 10 competent cells. Putative positive clones were again 
digested with XhoI/NotI to select for positive clones. The psiCHECK
TM
2 vector has 
a size of 6.3 kb and Sox11 1.2 kb. Two of the selected clones contained the full 
length Sox11 sequence (Figure 4.15).  
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Figure 4.15: Test digest of the psiCHECK
TM
2-Sox11. The putative positive clones 
were digested with XhoI and NotI. One of the positive clones (arrow) was selected to 
use in a further luciferase assay. M1kb: 1kb DNA marker (NEB). 
HEK 293T were transfected with 0.25 µg of the targeting sequence (psiCHECKTM2-
Sox11) and 0.25 µg of the respective shRNA (Sox11-sh-RNA-pLentiLox 3.7 or 
empty pLentiLox 3.7) to analyze the functionality of the Sox11-shRNAs in a 
luciferase assay. If shRNA led to the cleavage of the fused Renilla-targeting 
sequence, the signal of the Renilla-luciferase was decreased, since the cleavage of 
the chimeric mRNA resulted in a fast degradation of the whole mRNA molecule. 
The signal of the Renilla-luciferase was normalized against the firefly-luciferase to 
allow a qualitative analysis of the shRNA-efficiency after measuring the luciferase 
activity.   
4 Sox11 specific shRNAs and an unrelated shRNA as control were tested for 
knockdown of Sox11. Forty-eight hours post-transfection Renilla and firefly 
luciferase activities were measured using the Dual-Luciferase Reporter 1000 Assay 
(Promega, Germany). The normalized Renilla-luciferase activity of psiCHECK
TM
2-
Sox11 co-transfected with the empty pLentiLox 3.7 was set to 1 %. In relation to this 
Sox11-shRNA 1 reduced the expression of the target gene Sox11 up to 20%, Sox11-
shRNA 2 up to 40%, Sox11-shRNA 3 up to 62% and Sox11-shRNA 4 up to 25% 
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(Figure 4.16). Therefore, especially Sox11-shRNA 2 and 3 led to an efficient 
degradation of Sox11 in vitro, whereas Sox11-shRNA 1 and 4 are not sufficient to 
reduce the expression of Sox11 as shown in comparison with the unrelated shRNA. 
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Figure 4.16: Selection of the target sequence to knock-down Sox11 with the 
psiCHECK
TM
2 vector. Especially Sox11-shRNA 2 and 3 led to an efficient 
degradation of Sox11. Sox11-shRNA 1 reduced the expression of the target gene 
Sox11 up to 20%, Sox11-shRNA 2 up to 40%, Sox11-shRNA 3 up to 62% and 
Sox11-shRNA 4 up to 25%.  
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5. DISCUSSION & CONCLUSION 
Neurogenesis is a continuous process in most of the mammalian brains throughout 
the life that is demonstrated in the subventricular zone (SVZ) of the lateral ventricle 
and in the subgranular zone (SGZ). This dynamic process is regulated by both 
extrinsic and intrinsic factors. Although neurotransmitters, growth factors and some 
signaling pathways regulate neurogenesis extrinsically, several transcription factors 
play an important role on its regulation intrinsically.  
Aim of this study was to analyze the function of SRY box related high mobility 
group box (Sox) transcription factor Sox11 in neurogenic lineages in order to get a 
better understanding of adult neurogenesis regulation. Sox group transcription factors 
have regulatory functions during vertebrate CNS development. For instance the 
group B Sox proteins Sox1-3 were shown to keep neural cells undifferentiated by 
counteracting the activity of proneural proteins (Bylund et al., 2003; Graham et al., 
2003). Whereas the SoxC group proteins Sox11 and Sox4 might act as a regulator of 
later steps neurogenesis in embryo because both are expressed in neural progenitor 
cells that have already been fate committed to neuronal differentiation (Uwanogho et 
al., 1995; Bergsland et al., 2006). It is also known that high expression of Sox2 in 
undifferentiated cells of embryonic neural epithelium is decreased when the cells 
leave the epithelium and get differentiated into neurons, whereas Sox11 expression 
in this cell population increases when the cell get differentiated into neurons 
(Uwanogho et al., 1995). These data of the restricted expression pattern of Sox2 and 
Sox11 point out the possibility that Sox11 might control the switch from 
proliferation to neuronal differentiation during embryonic development. However up 
to now it was unknown if Sox11 also affects adult neurogenesis.  
Sox11 is expressed by newly born immature neurons in the RMS of the adult 
brain 
Sox11 is expressed in the olfactory bulb (OB) and hippocampus as shown by RT-
PCR and by immunohistochemical staining. It is known that there are type A 
immature migrating precursors in the RMS that express doublecortin (DCX) and ß-
III-tubulin (Tuj1). When the Sox11 staining was performed in combination with 
DCX and Tuj1, most of the Sox11 expressing cells were Tuj1 and/or DCX positive. 
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DCX is a microtubule-associated protein specifically and transiently expressed in all 
migrating proliferating neuronal progenitors and in post-mitotic neuronal precursors 
(Brown et al., 2003; Rao and Shetty, 2004; Coillard-Despres, 2001). On the other 
hand, Tuj1 is a neuron specific microtubule monomer transiently expressed in 
immature neuroblasts that acts on microtubule dynamicity (Roskams et al., 1998). 
Therefore we can conclude that in the RMS Sox11 is expressed in migrating 
neuronal precursors called type A cells.   
Sox11 is expressed by newly born immature neurons in the hippocampus of the 
adult brain 
RT PCR and immunohistochemical staining also revealed Sox11 expression in the 
hippocampal dentate gyrus. It was observed in the hippocampus that all of the Sox11 
positive cells were not positive for Sox2 or GFAP. In other words, there might be an 
on/off mechanism between Sox2 and Sox11. Sox2 expression might maintain 
stemness such as type 1 and 2a cells do, whereas Sox11 expressing cells might be 
related in fate specification such as type 2b and 3 are. So Sox11 expression might be 
important for lineage determination.  
It was shown that Sox11 immunoreactive cells were immature neurons that were also 
labeled with Tuj1, DCX and calretinin which are immature neuronal markers. In 
hippocampus, type 2b transiently amplifying progenitors express DCX and type 3 
lineage determined post-mitotic migrating precursors express both DCX and Tuj1. 
DCX expression is related to the entry of neuronal differentiation and migration 
(Francis et al., 1999). The expression pattern of Tuj1 is not known but its association 
with immature neurons is identified (Uittenbogaard and Chiaramello, 2002). 
Additionally, calretinin positive cells are post-mitotic and immature granule cells. 
Sox11 expression in both mitotic and post-mitotic cells represents that Sox11 does 
not involve in cell cycle exit (Bergsland et al., 2006).  
Lastly, Sox11 positive cells did not express calbindin that is a mature neuronal 
marker. We can say that Sox11 is not expressed in mature neurons. 
In conclusion, Sox11 expression pattern in neurogenic lineages shows that Sox11 
expression promotes neuronal differentiation. It might have a role in transition from 
multipotent stem cells to fate specified neuroblasts.  
Sox11 highly activates the DCX promoter  
The overlapped expression pattern of Sox11 and DCX leads to the question if Sox11 
acts upstream of DCX. It was observed by HEK 293T cells transient transfection that 
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the DCX promoter was highly activated by just 8 ng Sox11/ 3x10
6 
cells. In silico 
analyses revealed that the DCX promoter contain Sox11 specific binding sequences. 
Although it is a possibility that Sox11 might bind to these sequences to activate DCX 
promoter, binding assays such as chromatin immunoprecipitaion should be done to 
clarify Sox11 binding sites on DCX promoter. In a dose dependent experiment it was 
shown that even very small amounts of Sox11 are sufficient to activate the DCX 
promoter. Hence, Sox11 might be an upstream element of DCX. Additionally these 
results are supported by the observation that the staining of Sox11 is significantly 
weaker compared to DCX.  
Tuj1 promoter analysis with Sox11 
It was previously shown that Sox11 activates the upstream segment of the mouse 
Tuj1 promoter (Bergsland et al., 2007). To confirm this experiment Tuj1 promoter 5’ 
flanking regions were analyzed if Sox11 effects on them. Both 490 bp and 131 bp 
upstream regions of the rat Tuj1 gene were shown to be sufficient to drive the 
expression of a reporter gene in embryonic stem cells during neuronal differentiation 
were used (Dennis et al., 2002). In contrast to the results shown by Bergsland et al., 
there was less activation of Tuj1 promoter segments by Sox11. Although three Sox11 
binding sequences were identified on 490 bp upstream and one binding sequence was 
identified on 131 bp upstream of the Tuj1 gene, Sox11 did not highly activate the 
promoter segments in HEK 293 cells. This experiment was done just one time. To 
get a significant result it should be repeated at least 3 times. 
Overexpression of Sox11 induces DCX expression so promotes neuronal 
differentiation in AHPs 
In this study, Sox11 overexpression led to an induction of DCX expression in AHPs. 
Even AHPs overexpressing Sox11 that were kept under neuronal differentiating 
conditions without addition of any growth factor or serum exhibited an increased 
expression of DCX. This effect was even amplified when these cells were kept under 
differentiating conditions including forskoline and serum (FBS). Under these 
conditions Sox11 overexpression led an even stronger induction of DCX expression. 
These results were confirmed in two independent experiments either by 
electroporation or viral transduction of Sox11. Therefore it can be suggested that 
once the differentiation is started by external factors added to the media, Sox11 has 
an even higher induction capacity on DCX expression.  
These experiments demonstrate that Sox11 might be a regulator of neuronal 
differentiation. It promotes neuronal differentiation by inducing DCX expression and 
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maybe additional factors that are not identified yet. It is known that DCX is involved 
in migration of immature neurons, so Sox11 might also be involved in migration step 
of neurogenesis together with DCX.  For further step, Sox11 overexpression would 
be done in vivo with retrovirus injection to adult mouse hippocampus and then DCX 
antibody staining would be performed to see any effect on them. Furthermore after 
the viral injection, morphological changes of injected cells can also be analyzed. 
Because Sox11 is expressed in calretinin stage that is the period of dendrite and axon 
formation and functional maturation, it would be interesting to observe the injected 
cell electrophyisologically to test its functional integration. If Sox11 will be 
overexpressed in vivo, there might be more mature neurons developed by the 
activation of neuronal genes such as DCX in the DG. Furthermore Furthermore less 
immature neurons might be seen in the SGZ. Since the stem cell population would 
not be changed, more migrated and mature cells but less immature cells would be 
seen. 
In this study, Sox11 was overexpressed with the electroporation of CAG-Sox11-
IRES-GFP vector in AHPs. Sox11 expressing cells should have been detected by 
Sox11 specific antibody staining in the electroporated AHPs. Since Sox11 antibody 
staining was not specific in vitro, Sox11 expression was detected by GFP signal 
instead. The existence of GFP signal is not enough to prove that Sox11 is expressed 
in the cell. As the results of DCX promoter analysis would indirectly confirm the 
overexpression results, Sox11 expression was analyzed through DCX 
immunostaining based on Sox11 activating DCX promoter. For further experiments, 
specific Sox11 antibody staining should be performed to reveal the Sox11 expression 
more accurately. 
Two out of four generated shRNAs against Sox11 are functional   
Because the Sox11 gene have diverse role on embryonic development of different 
organs, Sox11 knockout mice dies at birth because of several organ defects (Sock et 
al., 2004). There is no chance to use knockout mice for adult analyses. Thus, to 
generate a tool for loss of function analysis of Sox11, four different shRNAs that 
contains different target sequences against Sox11 were produced to knockdown 
specifically Sox11. It was demonstrated by Western blot and psiCHECK system that 
shRNAs 2 and 3 were more efficiently silencing Sox11. Other shRNAs might be 
instable in the cell or they might have secondary structures that prevent access to the 
target mRNA. Further step with produced functional shRNAs will be to knockdown 
Sox11 in vivo by using shRNAs and to test if they are specific for Sox11. Because 
HMG domain of another SoxC group protein Sox4 has a great homology with Sox11 
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(92% in aminoacid homology) (Wright et al., 1993), the specificity of shRNA 
knockdown studies should be checked. After the Sox11 knock-down, its effects on 
neuronal differentiation would be analyzed. Sox4 and Sox11 have redundant 
functions (Lefebvre et al., 2007) therefore it is possible that one might compensate 
deficiency of the other one. If Sox11 would be knocked down, transition from stem 
like cells into neuronal lineage determined immature neurons would be affected. 
There might be less immature neurons that are DCX or Tuj1 positive.  
Briefly, this study demonstrated that Sox11 expression promotes neuronal 
differentiation in AHPs via inducing neuronal gene expression like DCX. 
Additionally, Sox11 might be an upstream regulator of DCX.  
 
 
Figure 5.1: Schema of Sox11 effect on neuronal differentiation 
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